[go: up one dir, main page]

WO2018187509A1 - Composés hétérocycliques utilisés en tant que modulateurs du récepteur de chimiokine - Google Patents

Composés hétérocycliques utilisés en tant que modulateurs du récepteur de chimiokine Download PDF

Info

Publication number
WO2018187509A1
WO2018187509A1 PCT/US2018/026139 US2018026139W WO2018187509A1 WO 2018187509 A1 WO2018187509 A1 WO 2018187509A1 US 2018026139 W US2018026139 W US 2018026139W WO 2018187509 A1 WO2018187509 A1 WO 2018187509A1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
unsubstituted
membered
cycloalkyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2018/026139
Other languages
English (en)
Inventor
Hilary Plake BECK
Berenger BIANNIC
Minna Hue Thanh BUI
Dennis X. HU
John Michael KETCHAM
Maureen Kay REILLY
Omar ROBLES-RESENDIZ
Hunter Paul SHUNATONA
James Ross WALKER
David Juergen Wustrow
Ashkaan Younai
Mikhail ZIBINSKY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flx Bio Inc
Original Assignee
Flx Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flx Bio Inc filed Critical Flx Bio Inc
Publication of WO2018187509A1 publication Critical patent/WO2018187509A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Definitions

  • Chemokines are a family of cytokines that act as chemoattractants to guide leukocyte migration. They are secreted by a wide variety of cells and can be functionally divided into two groups, hemostatic chemokines and inflammatory chemokines. Hemostatic chemokines are constituently produced in certain tissues and control cells of the immune system during processes of immune surveillance, such as directing lymphocytes to the lymph nodes to allow them to screen for invasion of pathogens.
  • Inflammatory chemokines are released from cells in response to a pathological event (e.g., pro-inflammatory stimuli such as IL-1 or viruses). They function primarily as chemoattractants as part of the inflammatory response and serve to guide cells of both the innate and adaptive immune systems to the site of inflammation.
  • the C-C chemokine receptor type 4 (CCR4), plays a role in the progression of a number of inflammation-related and other disorders. The identification of compounds that modulate CCR4 function is an ongoing challenge.
  • A is substituted or unsubstituted cycloalkyl or substituted or unsubstituted heterocycloalkyl.
  • X 1 is CR 8 or N.
  • X 2 is CR 9 or N.
  • X 3 is CR 10 or N.
  • X 4 is C, CR 11 or N.
  • X 7 is NR 17 or N, wherein when L 7 is covalently bound to X 7 , then X 7 is N. is a single bond or double bond, wherein if is a single bond, then X 4 is
  • L 7 is a bond, -0-, -S-, -NR 7B -, -C(O)-, - C(0)0-, -S(O) -, -S(0) 2 -, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted
  • R 3 is independently hydrogen, halogen, -CX 3.1 3, -
  • R 4 is hydrogen, halogen, -
  • R 5 is independently hydrogen
  • R 8 is hydrogen, halogen,
  • R 9 is hydrogen, halogen,
  • heterocycloalkyl substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • X 1 1 , X 2 1 , X 3 1 , X 4.1 , X 5 1 , X 6 1 , X 8 1 , X 9. 1 , X 10 1 , X 11 1 and X 17 1 are independently -CI, -Br, -I or -F. In embodiments, at least one of X 1 , X 2 and X 3 is N.
  • nl, n2, n3, n4, n5, n6, n8, n9, nlO, nl 1, and nl7 are independently an integer from 0 to 4.
  • the symbols ml , ml, m3, m4, m5, m6, m8, m9, mlO, ml 1, ml7, vl, v2, v3, v4, v5, v6, v8, v9, vlO, vl 1, and vl7 are independently 1 or 2.
  • the symbol zl is an integer from 0 to 5.
  • the symbol z2 is an integer from 0 to 8.
  • the symbol z3 is an integer from 0 to 12.
  • a pharmaceutical composition including a compound as described herein, including embodiments, or the structural Formula (I), (II), (III), (IV), (V) or (VI), and a pharmaceutically acceptable excipient.
  • CCR4 C-C chemokine receptor type 4
  • the method comprising contacting CCR4 with a compound as described herein, including embodiments, or the structural Formula (I), (II), (III), (IV), (V) or (VI), or a pharmaceutically acceptable salt thereof.
  • a method of treating or preventing a disease or disorder mediated by CCR4, comprising administering to a subject in need thereof a therapeutically effective amount of a compound as described herein, including embodiments, or the structural Formula (I), (II), (III), (IV), (V) or (VI), or a pharmaceutically acceptable salt thereof.
  • C-C chemokine receptor type 4 compounds and compositions for inhibition of C-C chemokine receptor type 4, and pharmaceutical compositions comprising same. Also provided herein are, for example, methods of treating or preventing a disease, disorder or condition, or a symptom thereof, mediated by modulation (e.g., inhibition) of CCR4.
  • alkyl by itself or as part of another substituent, means, unless otherwise stated, a straight (i.e., unbranched) or branched carbon chain (or carbon), or combination thereof, which may be fully saturated, mono- or polyunsaturated and can include mono-, di- and multivalent radicals, having the number of carbon atoms designated (i.e., C 1 -C10 means one to ten carbons). Alkyl is an uncyclized chain.
  • saturated hydrocarbon radicals include, but are not limited to, groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, isobutyl, sec-butyl, (cyclohexyl)methyl, homologs and isomers of, for example, n-pentyl, n- hexyl, n-heptyl, n-octyl, and the like.
  • An unsaturated alkyl group is one having one or more double bonds or triple bonds.
  • unsaturated alkyl groups include, but are not limited to, vinyl, 2-propenyl, crotyl, 2-isopentenyl, 2-(butadienyl), 2,4-pentadienyl, 3-(l ,4-pentadienyl), ethynyl, 1 - and 3-propynyl, 3-butynyl, and the higher homologs and isomers.
  • An alkoxy is an alkyl attached to the remainder of the molecule via an oxygen linker (-0-).
  • alkylene by itself or as part of another substituent, means, unless otherwise stated, a divalent radical derived from an alkyl, as exemplified, but not limited by, - Typically, an alkyl (or alkylene) group will have from 1 to 24 carbon atoms, with those groups having 10 or fewer carbon atoms being preferred herein.
  • a “lower alkyl” or “lower alkylene” is a shorter chain alkyl or alkylene group, generally having eight or fewer carbon atoms.
  • alkenylene by itself or as part of another substituent, means, unless otherwise stated, a divalent radical derived from an alkene.
  • heteroalkyl by itself or in combination with another term, means, unless otherwise stated, a stable straight or branched chain, or combinations thereof, including at least one carbon atom and at least one heteroatom (e.g., O, N, P, Si, and S), and wherein the nitrogen and sulfur atoms may optionally be oxidized, and the nitrogen heteroatom may optionally be quaternized.
  • the heteroatom(s) e.g., N, S, Si, or P
  • Heteroalkyl is an uncyclized chain. Examples include, but are not limited to: -CH2-
  • a heteroalkyl moiety may include one heteroatom (e.g., O, N, S, Si, or P).
  • a heteroalkyl moiety may include two optionally different heteroatoms (e.g., O, N, S, Si, or P).
  • a heteroalkyl moiety may include three optionally different heteroatoms (e.g., O, N, S, Si, or P).
  • a heteroalkyl moiety may include four optionally different heteroatoms (e.g., O, N, S, Si, or P).
  • a heteroalkyl moiety may include five optionally different heteroatoms (e.g., O, N, S, Si, or P).
  • a heteroalkyl moiety may include up to eight optionally different heteroatoms (e.g., O, N, S, Si, or P).
  • heteroalkylene by itself or as part of another substituent, means, unless otherwise stated, a divalent radical derived from heteroalkyl, as exemplified, but not limited by, -CH 2 -CH 2 -S-CH 2 -CH 2 - and -CH 2 -S-CH 2 -CH 2 -NH-CH 2 -.
  • heteroatoms can also occupy either or both of the chain termini (e.g., alkyleneoxy,
  • heteroalkyl groups include those groups that are attached to the remainder of the molecule through a heteroatom, such as - C(0)R', -C(0)NR', -NR'R", -OR', -SR', and/or -S0 2 R'.
  • heteroalkyl is recited, followed by recitations of specific heteroalkyl groups, such as -NR'R” or the like, it will be understood that the terms heteroalkyl and -NR'R" are not redundant or mutually exclusive. Rather, the specific heteroalkyl groups are recited to add clarity. Thus, the term “heteroalkyl” should not be interpreted herein as excluding specific heteroalkyl groups, such as -NR'R" or the like.
  • cycloalkyl and heterocycloalkyl by themselves or in combination with other terms, mean, unless otherwise stated, cyclic versions of “alkyl” and “heteroalkyl,” respectively. Cycloalkyl and heterocycloalkyl are not aromatic. Additionally, for
  • heterocycloalkyl a heteroatom can occupy the position at which the heterocycle is attached to the remainder of the molecule.
  • cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 1-cyclohexenyl, 3-cyclohexenyl, cycloheptyl, and the like.
  • heterocycloalkyl examples include, but are not limited to, 1 -(1,2,5,6- tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1- piperazinyl, 2-piperazinyl, and the like.
  • a "cycloalkylene” and a "heterocycloalkylene,” alone or as part of another substituent, means a divalent radical derived from a cycloalkyl and
  • heterocycloalkyl is also meant to refer to bicyclic and polycyclic hydrocarbon rings such as, for example, bicyclo[2.2.1 ]heptane, bicyclo[2.2.2]octane, etc.
  • halo or halogen
  • haloalkyl by themselves or as part of another substituent, mean, unless otherwise stated, a fluorine, chlorine, bromine, or iodine atom.
  • terms such as “haloalkyl” are meant to include monohaloalkyl and polyhaloalkyl.
  • halo(C 1 -C4)alkyl includes, but is not limited to, fluoromethyl, difluoromethyl, trifluorom ethyl, 2,2,2-trifluoroethyl, 4-chlorobutyl, 3-bromopropyl, and the like.
  • acyl means, unless otherwise stated, -C(0)R where R is a substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • aryl means, unless otherwise stated, a polyunsaturated, aromatic, hydrocarbon substituent, which can be a single ring or multiple rings (preferably from 1 to 3 rings) that are fused together (i.e., a fused ring aryl) or linked covalently.
  • a fused ring aryl refers to multiple rings fused together wherein at least one of the fused rings is an aryl ring.
  • heteroaryl refers to aryl groups (or rings) that contain at least one heteroatom such as N, O, or S, wherein the nitrogen and sulfur atoms are optionally oxidized, and the nitrogen atom(s) are optionally quaternized.
  • heteroaryl includes fused ring heteroaryl groups (i.e., multiple rings fused together wherein at least one of the fused rings is a heteroaromatic ring).
  • a 5,6-fused ring heteroarylene refers to two rings fused together, wherein one ring has 5 members and the other ring has 6 members, and wherein at least one ring is a heteroaryl ring.
  • a 6,6-fused ring heteroarylene refers to two rings fused together, wherein one ring has 6 members and the other ring has 6 members, and wherein at least one ring is a heteroaryl ring.
  • a 6,5- fused ring heteroarylene refers to two rings fused together, wherein one ring has 6 members and the other ring has 5 members, and wherein at least one ring is a heteroaryl ring.
  • a heteroaryl group can be attached to the remainder of the molecule through a carbon or heteroatom.
  • Non- limiting examples of aryl and heteroaryl groups include phenyl, naphthyl, pyrrolyl, pyrazolyl, pyridazinyl, triazinyl, pyrimidinyl, imidazolyl, pyrazinyl, purinyl, oxazolyl, isoxazolyl, thiazolyl, furyl, thienyl, pyridyl, pyrimidyl, benzothiazolyl, benzoxazoyl benzimidazolyl, benzofuran, isobenzofuranyl, indolyl, isoindolyl, benzothiophenyl, isoquinolyl, quinoxalinyl, quinolyl, 1- naphthyl, 2-naphthyl, 4-biphenyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 3-pyrazolyl, 2-imidazolyl, 4- imidazoly
  • arylene and heteroarylene are selected from the group of acceptable substituents described below.
  • a heteroaryl group substituent may be -O- bonded to a ring heteroatom nitrogen.
  • Spirocyclic rings are two or more rings wherein adjacent rings are attached through a single atom.
  • the individual rings within spirocyclic rings may be identical or different.
  • Individual rings in spirocyclic rings may be substituted or unsubstituted and may have different substituents from other individual rings within a set of spirocyclic rings. Possible substituents for individual rings within spirocyclic rings are the possible substituents for the same ring when not part of spirocyclic rings (e.g. substituents for cycloalkyl or heterocycloalkyl rings).
  • Spirocylic rings may be substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heterocycloalkylene and individual rings within a spirocyclic ring group may be any of the immediately previous list, including having all rings of one type (e.g. all rings being substituted heterocycloalkylene wherein each ring may be the same or different substituted heterocycloalkylene).
  • heterocyclic spirocyclic rings means a spirocyclic rings wherein at least one ring is a heterocyclic ring and wherein each ring may be a different ring.
  • substituted spirocyclic rings means that at least one ring is substituted and each substituent may optionally be different.
  • oxo means an oxygen that is double bonded to a carbon atom.
  • alkylarylene as an arylene moiety covalently bonded to an alkylene moiety (also referred to herein as an alkylene linker).
  • alkylarylene group has the formula:
  • An alkylarylene moiety may be substituted (e.g. with a substituent group) on the alkylene moiety or the arylene linker (e.g. at carbons 2, 3, 4, or 6) with halogen, oxo, -N 3 , -CF 3 , - CC1 3 , -CBr 3 , -CI 3 , -CN, -CHO, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 2 CH 3 -S0 3 H, - OS0 3 H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NFfNH 2 , substituted or unsubstituted C 1 -C5 alkyl or substituted or unsubstituted 2 to 5 membered heteroalkyl).
  • the alkylarylene is unsubstituted.
  • R, R, R", R'", and R" each preferably independently refer to hydrogen, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl (e.g., aryl substituted with 1-3 halogens), substituted or unsubstituted heteroaryl, substituted or
  • each of the R groups is independently selected as are each R', R", R'", and R"" group when more than one of these groups is present.
  • R' and R" are attached to the same nitrogen atom, they can be combined with the nitrogen atom to form a 4-, 5-, 6-, or 7-membered ring.
  • -NR'R includes, but is not limited to, 1 -pyrrolidinyl and 4-morpholinyl.
  • alkyl is meant to include groups including carbon atoms bound to groups other than hydrogen groups, such as haloalkyl (e.g., -CF 3 and -CH 2 CF 3 ) and acyl (e.g., -C(0)CH 3 , -C(0)CF 3 , -C(0)CH 2 OCH 3 , and the like).
  • haloalkyl e.g., -CF 3 and -CH 2 CF 3
  • acyl e.g., -C(0)CH 3 , -C(0)CF 3 , -C(0)CH 2 OCH 3 , and the like.
  • Substituents for rings may be depicted as substituents on the ring rather than on a specific atom of a ring (commonly referred to as a floating substituent).
  • the substituent may be attached to any of the ring atoms (obeying the rules of chemical valency) and in the case of fused rings or spirocyclic rings, a substituent depicted as associated with one member of the fused rings or spirocyclic rings (a floating substituent on a single ring), may be a substituent on any of the fused rings or spirocyclic rings (a floating substituent on multiple rings).
  • the multiple substituents may be on the same atom, same ring, different atoms, different fused rings, different spirocyclic rings, and each substituent may optionally be different.
  • a point of attachment of a ring to the remainder of a molecule is not limited to a single atom (a floating substituent)
  • the attachment point may be any atom of the ring and in the case of a fused ring or spirocyclic ring, any atom of any of the fused rings or spirocyclic rings while obeying the rules of chemical valency.
  • a ring, fused rings, or spirocyclic rings contain one or more ring heteroatoms and the ring, fused rings, or spirocyclic rings are shown with one more floating substituents (including, but not limited to, points of attachment to the remainder of the molecule), the floating substituents may be bonded to the heteroatoms.
  • the ring heteroatoms are shown bound to one or more hydrogens (e.g. a ring nitrogen with two bonds to ring atoms and a third bond to a hydrogen) in the structure or formula with the floating substituent, when the heteroatom is bonded to the floating substituent, the substituent will be understood to replace the hydrogen, while obeying the rules of chemical valency.
  • Two or more substituents may optionally be joined to form aryl, heteroaryl, cycloalkyl, or heterocycloalkyl groups.
  • Such so-called ring- forming substituents are typically, though not necessarily, found attached to a cyclic base structure.
  • the ring-forming substituents are attached to adjacent members of the base structure.
  • two ring-forming substituents attached to adjacent members of a cyclic base structure create a fused ring structure.
  • the ring-forming substituents are attached to a single member of the base structure.
  • two ring-forming substituents attached to a single member of a cyclic base structure create a spirocyclic structure.
  • the ring- forming substituents are attached to non-adjacent members of the base structure.
  • Two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally form a ring of the formula -T-C(0)-(CRR') q -U-, wherein T and U are independently -NR-, -0-, - CRR'-, or a single bond, and q is an integer of from 0 to 3.
  • two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -A-(CH 2 ) r -B-, wherein A and B are independently -CRR'-, -0-, -NR-, -S-, -S(O) -, - S(0) 2 -, -S(0) 2 NR'-, or a single bond, and r is an integer of from 1 to 4.
  • One of the single bonds of the new ring so formed may optionally be replaced with a double bond.
  • two of the substituents on adjacent atoms of the aryl or heteroaryl ring may optionally be replaced with a substituent of the formula -(CRR')s-X'- (C"R"R"')d-, where s and d are independently integers of from 0 to 3, and X' is -0-, -NR'-, -S-, -S(O)-, -S(0) 2 -, or -S(0) 2 NR'-.
  • R, R, R", and R' are preferably independently selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl.
  • heteroatom or "ring heteroatom” are meant to include oxygen (O), nitrogen (N), sulfur (S), phosphorus (P), and silicon (Si).
  • a "substituent group,” as used herein, means a group selected from the following moieties:
  • NHS0 2 H, -NHC (O)H, -NHC(0)-OH, -NHOH, -OCF 3 , -OCHF 2 , unsubstituted alkyl, unsubstituted heteroalkyl, unsubstituted cycloalkyl, unsubstituted heterocycloalkyl, unsubstituted aryl, unsubstituted heteroaryl, and
  • a "size-limited substituent” or " size-limited substituent group,” as used herein, means a group selected from all of the substituents described above for a "substituent group,” wherein each substituted or unsubstituted alkyl is a substituted or unsubstituted C 1 -C 20 alkyl, each substituted or unsubstituted heteroalkyl is a substituted or unsubstituted 2 to 20 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is a substituted or unsubstituted C 3 -C 8 cycloalkyl, each substituted or unsubstituted heterocycloalkyl is a substituted or unsubstituted 3 to 8 membered heterocycloalkyl, each substituted or unsubstituted aryl is a substituted or unsubstituted C 6 -C10 aryl, and each substituted or unsubstituted heteroary
  • a "lower substituent” or " lower substituent group,” as used herein, means a group selected from all of the substituents described above for a "substituent group,” wherein each substituted or unsubstituted alkyl is a substituted or unsubstituted C 1 -C 8 alkyl, each substituted or unsubstituted heteroalkyl is a substituted or unsubstituted 2 to 8 membered heteroalkyl, each substituted or unsubstituted cycloalkyl is a substituted or unsubstituted C 3 -C7 cycloalkyl, each substituted or unsubstituted heterocycloalkyl is a substituted or unsubstituted 3 to 7 membered heterocycloalkyl, each substituted or unsubstituted aryl is a substituted or unsubstituted C 6 -C10 aryl, and each substituted or unsubstituted heteroaryl is
  • each substituted group described in the compounds herein is substituted with at least one substituent group. More specifically, in some embodiments, each substituted alkyl, substituted heteroalkyl, substituted cycloalkyl, substituted heterocycloalkyl, substituted aryl, substituted heteroaryl, substituted alkylene, substituted heteroalkylene, substituted cycloalkylene, substituted heterocycloalkylene, substituted arylene, and/or substituted heteroarylene described in the compounds herein are substituted with at least one substituent group. In other embodiments, at least one or all of these groups are substituted with at least one size-limited substituent group. In other embodiments, at least one or all of these groups are substituted with at least one lower substituent group.
  • each substituted or unsubstituted alkyl may be a substituted or unsubstituted C 1 -C 20 alkyl
  • each substituted or unsubstituted heteroalkyl is a substituted or unsubstituted 2 to 20 membered heteroalkyl
  • each substituted or unsubstituted cycloalkyl is a substituted or unsubstituted C 3 -C 8 cycloalkyl
  • each substituted or unsubstituted heterocycloalkyl is a substituted or unsubstituted 3 to 8 membered heterocycloalkyl
  • each substituted or unsubstituted aryl is a substituted or unsubstituted C 6 -C 10 aryl
  • each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5 to 10 membered heteroaryl.
  • each substituted or unsubstituted alkylene is a substituted or unsubstituted C 1 -C 20 alkylene
  • each substituted or unsubstituted heteroalkylene is a substituted or unsubstituted 2 to 20 membered heteroalkylene
  • each substituted or unsubstituted cycloalkylene is a substituted or unsubstituted C 3 -C 8 cycloalkylene
  • each substituted or unsubstituted heterocycloalkylene is a substituted or unsubstituted 3 to 8 membered heterocycloalkylene
  • each substituted or unsubstituted arylene is a substituted or unsubstituted C 6 -C 10 arylene
  • each substituted or unsubstituted heteroarylene is a substituted or unsubstituted 5 to 10 membered heteroarylene.
  • each substituted or unsubstituted alkyl is a substituted or unsubstituted C 1 -C 8 alkyl
  • each substituted or unsubstituted heteroalkyl is a substituted or unsubstituted 2 to 8 membered heteroalkyl
  • each substituted or unsubstituted cycloalkyl is a substituted or unsubstituted C 3 -C7 cycloalkyl
  • each substituted or unsubstituted heterocycloalkyl is a substituted or unsubstituted 3 to 7 membered heterocycloalkyl
  • each substituted or unsubstituted aryl is a substituted or unsubstituted C 6 -C 10 aryl
  • each substituted or unsubstituted heteroaryl is a substituted or unsubstituted 5 to 9 membered heteroaryl.
  • each substituted or unsubstituted alkylene is a substituted or unsubstituted C 1 -C 8 alkylene
  • each substituted or unsubstituted heteroalkylene is a substituted or unsubstituted 2 to 8 membered heteroalkylene
  • each substituted or unsubstituted cycloalkylene is a substituted or unsubstituted C 3 -C7 cycloalkylene
  • each substituted or unsubstituted heterocycloalkylene is a substituted or unsubstituted 3 to 7 membered heterocycloalkylene
  • each substituted or unsubstituted arylene is a substituted or unsubstituted C 6 -C10 arylene
  • each substituted or unsubstituted heteroarylene is a substituted or unsubstituted 5 to 9 membered heteroarylene.
  • the compound is a chemical species set forth in the Examples section, figures, or tables
  • Certain compounds disclosed herein possess asymmetric carbon atoms (optical or chiral centers) or double bonds; the enantiomers, racemates, diastereomers, tautomers, geometric isomers, stereoisometric forms that may be defined, in terms of absolute stereochemistry, as (R)- or (S)- or, as (D)- or (L)- for amino acids, and individual isomers are encompassed within the scope of the presentdisclosure.
  • the compounds of the present disclosure do not include those that are known in art to be too unstable to synthesize and/or isolate.
  • the presently disclosed compounds include compounds in racemic and optically pure forms.
  • Optically active (R)- and (S)-, or (D)- and (L)-isomers may be prepared using chiral synthons or chiral reagents, or resolved using conventional techniques.
  • the compounds described herein contain olefinic bonds or other centers of geometric asymmetry, and unless specified otherwise, it is intended that the compounds include both E and Z geometric isomers.
  • isomers refers to compounds having the same number and kind of atoms, and hence the same molecular weight, but differing in respect to the structural arrangement or configuration of the atoms.
  • tautomer refers to one of two or more structural isomers which exist in equilibrium and which are readily converted from one isomeric form to another.
  • structures depicted herein are also meant to include all stereochemical forms of the structure; i.e., the R and S configurations for each asymmetric center. Therefore, single stereochemical isomers as well as enantiomeric and diastereomeric mixtures of the present compounds are within the scope hereof.
  • structures depicted herein are also meant to include compounds which differ only in the presence of one or more isotopically enriched atoms.
  • compounds having the present structures except for the replacement of a hydrogen by a deuterium or tritium, or the replacement of a carbon by 13 C- or 14 C-enriched carbon are within the scope hereof.
  • the compounds of the present disclosure may also contain unnatural proportions of atomic isotopes at one or more of the atoms that constitute such compounds.
  • the compounds may be radiolabeled with radioactive isotopes, such as for example tritium ( 3 H), iodine- 125 ( 125 I), or carbon- 14 ( 14 C). All isotopic variations of the compounds of the
  • presentdisclosure whether radioactive or not, are encompassed within the scope of the presentdisclosure.
  • an analog is used in accordance with its plain ordinary meaning within Chemistry and Biology and refers to a chemical compound that is structurally similar to another compound (i.e., a so-called “reference” compound) but differs in composition, e.g., in the replacement of one atom by an atom of a different element, or in the presence of a particular functional group, or the replacement of one functional group by another functional group, or the absolute stereochemistry of one or more chiral centers of the reference compound. Accordingly, an analog is a compound that is similar or comparable in function and appearance but not in structure or origin to a reference compound.
  • a or “an,” as used in herein means one or more.
  • substituted with a[n] means the specified group may be substituted with one or more of any or all of the named substituents.
  • a group such as an alkyl or heteroaryl group
  • the group may contain one or more unsubstituted C 1 -C 20 alkyls, and/or one or more unsubstituted 2 to 20 membered heteroalkyls.
  • R-substituted where a moiety is substituted with an R substituent, the group may be referred to as "R-substituted.” Where a moiety is R-substituted, the moiety is substituted with at least one R substituent and each R substituent is optionally different. Where a particular R group is present in the description of a chemical genus (such as Formula (I)), a Roman alphabetic symbol may be used to distinguish each appearance of that particular R group. For example, where multiple R 13 substituents are present, each R 13 substituent may be distinguished as R 13A , R 13B , R 13C , R 13D , etc., wherein each of R 13A , R 13B , R 13C , R 13D , etc. is defined within the scope of the definition of R 13 and optionally differently.
  • a "detectable moiety” as used herein refers to a moiety that can be covalently or noncovalently attached to a compound or biomolecule that can be detected for instance, using techniques known in the art.
  • the detectable moiety is covalently attached.
  • the detectable moiety may provide for imaging of the attached compound or biomolecule.
  • the detectable moiety may indicate the contacting between two compounds.
  • Exemplary detectable moieties are fluorophores, antibodies, reactive dies, radio-labeled moieties, magnetic contrast agents, and quantum dots.
  • Exemplary fluorophores include fluorescein, rhodamine, GFP, coumarin, FITC, Alexa fluor, Cy3, Cy5, BODIPY, and cyanine dyes.
  • Exemplary radionuclides include Fluorine- 18, Gallium-68, and Copper-64.
  • Exemplary magnetic contrast agents include gadolinium, iron oxide and iron platinum, and manganese.
  • salts are meant to include salts of the active compounds that are prepared with relatively nontoxic acids or bases, depending on the particular substituents found on the compounds described herein.
  • base addition salts can be obtained by contacting the neutral form of such compounds with a sufficient amount of the desired base, either neat or in a suitable inert solvent.
  • pharmaceutically acceptable base addition salts include sodium, potassium, calcium, ammonium, organic amino, or magnesium salt, or a similar salt.
  • acid addition salts can be obtained by contacting the neutral form of such compounds with a sufficient amount of the desired acid, either neat or in a suitable inert solvent.
  • pharmaceutically acceptable acid addition salts include those derived from inorganic acids like hydrochloric, hydrobromic, nitric, carbonic, monohydrogencarbonic, phosphoric,
  • the compounds of the present disclosure may exist as salts, such as with pharmaceutically acceptable acids.
  • the present disclosure includes such salts.
  • Non-limiting examples of such salts include hydrochlorides, hydrobromides, phosphates, sulfates,
  • methanesulfonates nitrates, maleates, acetates, citrates, fumarates, proprionates, tartrates (e.g., (+)-tartrates, (-)-tartrates, or mixtures thereof including racemic mixtures), succinates, benzoates, and salts with amino acids such as glutamic acid, and quaternary ammonium salts (e.g. methyl iodide, ethyl iodide, and the like). These salts may be prepared by methods known to those skilled in the art. [0052] The neutral forms of the compounds are preferably regenerated by contacting the salt with a base or acid and isolating the parent compound in the conventional manner.
  • the parent form of the compound may differ from the various salt forms in certain physical properties, such as solubility in polar solvents.
  • compounds of the present disclosure contain both basic and acidic functionalities that allow the compounds to be converted into either base or acid addition salts.
  • the neutral forms of the compounds may be regenerated by contacting the salt with a base or acid and isolating the parent compound in a conventional manner.
  • the parent form of the compounds differs from the various salt forms in certain physical properties, such as solubility in polar solvents, but, unless specifically indicated, the salts disclosed herein are equivalent to the parent form of the compound for the purposes of the present disclosure.
  • the present disclosure provides compounds which are in a prodrug form.
  • Prodrugs of the compounds described herein are those compounds that readily undergo chemical changes under physiological conditions to provide the compounds of the present disclosure.
  • Prodrugs of the compounds described herein may be converted in vivo after administration.
  • prodrugs can be converted to the compounds of the present disclosure by chemical or biochemical methods in an ex vivo environment, such as, for example, when contacted with a suitable enzyme or chemical reagent.
  • Certain compounds of the present disclosure can exist in unsolvated forms as well as solvated forms, including hydrated forms. In general, the solvated forms are equivalent to unsolvated forms and are encompassed within the scope of the present disclosure. Certain compounds of the present disclosure may exist in multiple crystalline or amorphous forms. In general, all physical forms are equivalent for the uses contemplated by the present disclosure and are intended to be within the scope of the present disclosure.
  • “Pharmaceutically acceptable excipient” and “pharmaceutically acceptable carrier” refer to a substance that aids the administration of a compound to and absorption by a subject and can be included in the compositions of the present disclosure without causing a significant adverse toxicological effect on the patient.
  • Non-limiting examples of pharmaceutically acceptable excipients include water, NaCl, normal saline solutions, lactated Ringer's, normal sucrose, normal glucose, binders, fillers, disintegrants, lubricants, coatings, sweeteners, flavors, salt solutions (such as Ringer's solution), alcohols, oils, gelatins, carbohydrates such as lactose, amylose or starch, fatty acid esters, hydroxymethycellulose, polyvinyl pyrrolidine, and colors, and the like.
  • Such preparations can be sterilized and, if desired, mixed with auxiliary agents such as lubricants, preservatives, stabilizers, wetting agents, emulsifiers, salts for influencing osmotic pressure, buffers, coloring, and/or aromatic substances and the like that do not deleteriously react with the compounds of the disclosure.
  • auxiliary agents such as lubricants, preservatives, stabilizers, wetting agents, emulsifiers, salts for influencing osmotic pressure, buffers, coloring, and/or aromatic substances and the like that do not deleteriously react with the compounds of the disclosure.
  • auxiliary agents such as lubricants, preservatives, stabilizers, wetting agents, emulsifiers, salts for influencing osmotic pressure, buffers, coloring, and/or aromatic substances and the like that do not deleteriously react with the compounds of the disclosure.
  • preparation is intended to include the formulation of the active compound with encapsulating material as a carrier providing a capsule in which the active component with or without other carriers, is surrounded by a carrier, which is thus in association with it.
  • cachets and lozenges are included. Tablets, powders, capsules, pills, cachets, and lozenges can be used as solid dosage forms suitable for oral administration.
  • CCR4 inhibitor refers to a compound (e.g., compounds described herein) that reduces the activity of CCR4 when compared to a control, such as absence of the compound or a compound with known inactivity.
  • polypeptide peptide
  • protein protein
  • amino acid polymers in which one or more amino acid residue is an artificial chemical mimetic of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers and non-naturally occurring amino acid polymer.
  • polypeptide refers to a polymeric form of amino acids of any length, which can include genetically coded and non-genetically coded amino acids, chemically or biochemically modified or derivatized amino acids, and polypeptides having modified polypeptide backbones.
  • the terms include fusion proteins, including, but not limited to, fusion proteins with a heterologous amino acid sequence; fusion proteins with heterologous and homologous leader sequences, with or without N-terminus methionine residues;
  • a polypeptide, or a cell is "recombinant" when it is artificial or engineered, or derived from or contains an artificial or engineered protein or nucleic acid (e.g. non-natural or not wild type).
  • a polynucleotide that is inserted into a vector or any other heterologous location, e.g., in a genome of a recombinant organism, such that it is not associated with nucleotide sequences that normally flank the polynucleotide as it is found in nature is a recombinant polynucleotide.
  • a protein expressed in vitro or in vivo from a recombinant polynucleotide is an example of a recombinant polypeptide.
  • a polynucleotide sequence that does not appear in nature for example a variant of a naturally occurring gene, is
  • Contacting is used in accordance with its plain ordinary meaning and refers to the process of allowing at least two distinct species (e.g. chemical compounds including
  • the resulting reaction product can be produced directly from a reaction between the added reagents or from an intermediate from one or more of the added reagents that can be produced in the reaction mixture.
  • contacting may include allowing two species to react, interact, or physically touch, wherein the two species may be a compound as described herein and a protein or enzyme.
  • contacting includes allowing a compound described herein to interact with a protein or enzyme that is involved in a signaling pathway (e.g., MAP kinase pathway).
  • activation As defined herein, the term “activation”, “activate”, “activating” and the like in reference to a protein refers to conversion of a protein into a biologically active derivative from an initial inactive or deactivated state.
  • the terms reference activation, or activating, sensitizing, or up-regulating signal transduction or enzymatic activity or the amount of a protein decreased in a disease.
  • agonist refers to a substance capable of detectably increasing the expression or activity of a given gene or protein.
  • the agonist can increase expression or activity 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or more in comparison to a control in the absence of the agonist. In certain instances, expression or activity is 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 10-fold or higher than the expression or activity in the absence of the agonist.
  • an agonist is a molecule that interacts with a target to cause or promote an increase in the activation of the target.
  • activators are molecules that increase, activate, facilitate, enhance activation, sensitize, or up-regulate, e.g., a gene, protein, ligand, receptor, or cell.
  • inhibition means negatively affecting (e.g. decreasing) the activity or function of the protein relative to the activity or function of the protein in the absence of the inhibitor.
  • inhibition means negatively affecting (e.g. decreasing) the activity or function of the protein relative to the activity or function of the protein in the absence of the inhibitor.
  • inhibition refers to reduction of a disease or symptoms of disease. In embodiments, inhibition refers to a reduction in the activity of a particular protein target. Thus, inhibition includes, at least in part, partially or totally blocking stimulation, decreasing, preventing, or delaying activation, or inactivating, desensitizing, or down-regulating signal transduction or enzymatic activity or the amount of a protein. In embodiments, inhibition refers to a reduction of activity of a target protein resulting from a direct interaction (e.g. an inhibitor binds to the target protein). In embodiments, inhibition refers to a reduction of activity of a target protein from an indirect interaction (e.g., an inhibitor binds to a protein that activates the target protein, thereby preventing target protein activation).
  • inhibitor refers to a substance capable of detectably decreasing the expression or activity of a given gene or protein.
  • the antagonist can decrease expression or activity 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or more in comparison to a control in the absence of the antagonist. In certain instances, expression or activity is 1.5-fold, 2-fold, 3-fold, 4-fold, 5-fold, 10-fold or lower than the expression or activity in the absence of the antagonist.
  • An antagonist prevents, reduces, inhibits, or neutralizes the activity of an agonist, and an antagonist can also prevent, inhibit, or reduce constitutive activity of a target, e.g., a target receptor, even where there is no identified agonist.
  • inhibitors are molecules that decrease, block, prevent, delay activation, inactivate, desensitize, or down-regulate, e.g., a gene, protein, ligand, receptor, or cell.
  • An inhibitor may also be defined as a molecule that reduces, blocks, or inactivates a constitutive activity.
  • An "antagonist” is a molecule that opposes the action(s) of an agonist.
  • C-C chemokine receptor type 4" and “CCR4" refer to a protein (including homologs, isoforms, and functional fragments thereof) and is a high affinity receptor for the C-C - type chemokines (e.g., CCL2 (MCP- 1), CCL4 (MIP-1), CCL5 (RANTES), CCL17 (TARC), and CCL22 (MDC)). It is referred to by a number of different names in the scientific literature, including "CC-CKR-4", “C-C CKR-4”, “K5-5", "CD194", “CMKBR4", "ChemR13", “HGCN”, and "14099".
  • the term includes any recombinant or naturally-occurring form of CCR4 variants thereof that maintain CCR4 activity (e.g. within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to wildtype CCR4).
  • the term includes any mutant form of CCR4 variants (e.g., frameshift mutations) thereof that maintain CCR4 activity (e.g. within at least 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 100% activity compared to wildtype CCR4).
  • the CCR4 protein encoded by the CCR4 gene has the amino acid sequence set forth in or corresponding to Entrez 1233, UniProt P51679, or RefSeq (protein) NP 005499.1.
  • the CCR4 gene has the nucleic acid sequence set forth in RefSeq (mR A) NM_005508.
  • the amino acid sequence or nucleic acid sequence is the sequence known at the time of filing of the present application.
  • the sequence corresponds to GL5031627.
  • the sequence corresponds to
  • the sequence corresponds to NM_005508.4. In embodiments, the sequence corresponds to GL48762930.
  • the CCR4 is a human CCR4, such as a human cancer causing CCR4. Though frequently found on dendritic cells, macrophages, NK cells, platelets, and basophils, CCR4 is predominantly associated with T cells. It plays a role in the progression of multiple inflammation-related disorders, and, as described herein, has also been implicated in a number of other conditions.
  • CCR4 The genomic sequence of CCR4 is present on chromosome 3 (NC_000003.12), and the CCR4 gene is conserved in a number of species, including chimpanzee, Rhesus monkey, dog, cow, mouse, rat, chicken, and zebrafish.
  • the CCR4 polypeptide comprises 360 amino acid residues (NP 005499.1), and, like other chemokine receptors, CCR4 is a G protein-coupled receptor found on the surface of leukocytes (see Horuk (1994) Trends Pharm. Sci. 15: 159-165).
  • expression includes any step involved in the production of the polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post- translational modification, and secretion. Expression can be detected using conventional techniques for detecting protein (e.g. , ELISA, Western blotting, flow cytometry,
  • the terms "disease” or “condition” refer to a state of being or health status of a patient or subject capable of being treated with the compounds or methods provided herein.
  • the disease may be a cancer.
  • the disease may be an autoimmune disease.
  • the disease may be an
  • cancer refers to human cancers and carcinomas, sarcomas, adenocarcinomas, lymphomas, leukemias, etc., including solid and lymphoid cancers, kidney, breast, lung, bladder, colon, ovarian, prostate, pancreas, stomach, brain, head and neck, skin, uterine, testicular, glioma, esophagus, and liver cancer, including hepatocarcinoma, lymphoma, including B-acute lymphoblastic lymphoma, non-Hodgkin's lymphomas (e.g., Burkitt's, Small Cell, and Large Cell lymphomas), Hodgkin's lymphoma, leukemia (including MDS, AML, ALL, ATLL and CML), or multiple myeloma.
  • cancer refers to human cancers and carcinomas, sarcomas, adenocarcinomas, lymphomas, leukemias, etc., including solid and lymphoid cancers
  • inflammatory disease refers to a disease or condition characterized by aberrant inflammation (e.g. an increased level of inflammation compared to a control such as a healthy person not suffering from a disease).
  • inflammatory diseases include autoimmune diseases, arthritis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, multiple sclerosis, systemic lupus erythematosus (SLE), myasthenia gravis, juvenile onset diabetes, diabetes mellitus type 1 , Guillain-Barre syndrome, Hashimoto's encephalitis, Hashimoto's thyroiditis, ankylosing spondylitis, psoriasis, Sjogren's
  • inflammatory-related diseases, disorders and conditions which may, for example, be caused by inflammatory cytokines, include, arthritis, kidney failure, lupus, asthma, psoriasis, colitis, pancreatitis, allergies, fibrosis, surgical complications (e.g., where inflammatory cytokines prevent healing), anemia, and fibromyalgia.
  • diseases and disorders which may be associated with chronic inflammation include Alzheimer's disease, congestive heart failure, stroke, aortic valve stenosis, arteriosclerosis, osteoporosis, Parkinson's disease, infections, inflammatory bowel disease (IBD), allergic contact dermatitis and other eczemas, systemic sclerosis, transplantation and multiple sclerosis.
  • IBD inflammatory bowel disease
  • cancer refers to all types of cancer, neoplasm or malignant tumors found in mammals (e.g. humans), including leukemia, carcinomas and sarcomas.
  • Exemplary cancers that may be treated with a compound or method provided herein include brain cancer, glioma, glioblastoma, neuroblastoma, prostate cancer, colorectal cancer, pancreatic cancer, cervical cancer, gastric cancer, ovarian cancer, lung cancer, and cancer of the head.
  • Exemplary cancers that may be treated with a compound or method provided herein include cancer of the thyroid, endocrine system, brain, breast, cervix, colon, head & neck, liver, kidney, lung, non-small cell lung, melanoma, mesothelioma, ovary, sarcoma, stomach, uterus,
  • Medulloblastoma colorectal cancer, pancreatic cancer. Additional examples include, thyroid carcinoma, cholangiocarcinoma, pancreatic adenocarcinoma, skin cutaneous melanoma, colon adenocarcinoma, rectum adenocarcinoma, stomach adenocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, breast invasive carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma, multiple myeloma, neuroblastoma, glioma, glioblastoma multiforme, ovarian cancer, rhabdomyosarcoma, primary thrombocytosis, primary macroglobulinemia, primary brain tumors, cancer, malignant pancreatic insulanoma, malignant carcinoid, urinary bladder cancer, premalignant skin lesions, testicular cancer
  • leukemia refers broadly to progressive, malignant diseases of the blood- forming organs and is generally characterized by a distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemia is generally clinically classified on the basis of (1) the duration and character of the disease-acute or chronic; (2) the type of cell involved; myeloid (myelogenous), lymphoid (lymphogenous), or monocytic; and (3) the increase or non-increase in the number abnormal cells in the blood-leukemic or aleukemic (subleukemic).
  • Exemplary leukemias that may be treated with a compound or method provided herein include, for example, acute nonlymphocytic leukemia, chronic lymphocytic leukemia, acute granulocytic leukemia, chronic granulocytic leukemia, acute promyelocytic leukemia, adult T-cell leukemia, aleukemic leukemia, a leukocythemic leukemia, basophylic leukemia, blast cell leukemia, bovine leukemia, chronic myelocytic leukemia, leukemia cutis, embryonal leukemia, eosinophilic leukemia, Gross' leukemia, hairy-cell leukemia, hemoblastic leukemia,
  • hemocytoblastic leukemia histiocytic leukemia, stem cell leukemia, acute monocytic leukemia, leukopenic leukemia, lymphatic leukemia, lymphoblastic leukemia, lymphocytic leukemia, lymphogenous leukemia, lymphoid leukemia, lymphosarcoma cell leukemia, mast cell leukemia, megakaryocyte leukemia, micromyeloblastic leukemia, monocytic leukemia, myeloblastic leukemia, myelocytic leukemia, myeloid granulocytic leukemia, myelomonocytic leukemia, Naegeli leukemia, plasma cell leukemia, multiple myeloma, plasmacytic leukemia,
  • sarcoma generally refers to a tumor which is made up of a substance like the embryonic connective tissue and is generally composed of closely packed cells embedded in a fibrillar or homogeneous substance.
  • Sarcomas that may be treated with a compound or method provided herein include a chondrosarcoma, fibrosarcoma, lymphosarcoma, melanosarcoma, myxosarcoma, osteosarcoma, Abemethy's sarcoma, adipose sarcoma, liposarcoma, alveolar soft part sarcoma, ameloblastic sarcoma, botryoid sarcoma, chloroma sarcoma, chorio carcinoma, embryonal sarcoma, Wilms' tumor sarcoma, endometrial sarcoma, stromal sarcoma, Ewing's sarcoma, fascial sar
  • melanoma is taken to mean a tumor arising from the melanocytic system of the skin and other organs.
  • Melanomas that may be treated with a compound or method provided herein include, for example, acral-lentiginous melanoma, amelanotic melanoma, benign juvenile melanoma, Cloudman's melanoma, S91 melanoma, Harding-Passey melanoma, juvenile melanoma, lentigo maligna melanoma, malignant melanoma, nodular melanoma, subungal melanoma, or superficial spreading melanoma.
  • carcinoma refers to a malignant new growth made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases.
  • exemplary carcinomas that may be treated with a compound or method provided herein include, for example, thyroid carcinoma, cholangiocarcinoma, pancreatic adenocarcinoma, skin cutaneous melanoma, colon adenocarcinoma, rectum adenocarcinoma, stomach adenocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, breast invasive carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, medullary thyroid carcinoma, familial medullary thyroid carcinoma, acinar carcinoma, acinous carcinoma, adenocystic carcinoma, adenoid cystic carcinoma, carcinoma adenomatosum, carcinoma of adrenal cortex, alveolar carcinoma, alveolar cell carcinoma, basal cell carcinoma, carcinoma basocellulare
  • autoimmune disease refers to a disease or condition in which a subject's immune system has an aberrant immune response against a substance that does not normally elicit an immune response in a healthy subject.
  • autoimmune diseases include Acute Disseminated Encephalomyelitis (ADEM), Acute necrotizing hemorrhagic leukoencephalitis, Addison's disease, Agammaglobulinemia, Alopecia areata, Amyloidosis, Ankylosing spondylitis, Anti-GBM/Anti-TBM nephritis, Antiphospholipid syndrome (APS), Autoimmune angioedema, Autoimmune aplastic anemia, Autoimmune dysautonomia,
  • Autoimmune inner ear disease AIED
  • Autoimmune myocarditis Autoimmune myocarditis
  • Autoimmune oophoritis Autoimmune pancreatitis
  • Autoimmune retinopathy Autoimmune thrombocytopenic purpura (ATP)
  • Autoimmune thyroid disease Autoimmune urticaria, Axonal or neuronal neuropathies, Balo disease, Behcet's disease, Bullous pemphigoid, Cardiomyopathy, Castleman disease, Celiac disease, Chagas disease, Chronic fatigue syndrome, Chronic inflammatory demyelinating polyneuropathy (CIDP), Chronic recurrent multifocal ostomyelitis (CRMO), Churg-Strauss syndrome, Cicatricial pemphigoid/benign mucosal pemphigoid, Crohn's disease, Cogans syndrome, Cold agglutinin disease, Congenital heart block, Coxsackie myocarditis, CREST
  • Hashimoto's thyroiditis Hemolytic anemia, Henoch-Schonlein purpura, Herpes gestationis, Hypogammaglobulinemia, Idiopathic thrombocytopenic purpura (ITP), IgA nephropathy, IgG4- related sclerosing disease, Immunoregulatory lipoproteins, Inclusion body myositis, Interstitial cystitis, Juvenile arthritis, Juvenile diabetes (Type 1 diabetes), Juvenile myositis, Kawasaki syndrome, Lambert-Eaton syndrome, Leukocytoclastic vasculitis, Lichen planus, Lichen sclerosus, Ligneous conjunctivitis, Linear IgA disease (LAD), Lupus (SLE), Lyme disease, chronic, Meniere's disease, Microscopic polyangiitis, Mixed connective tissue disease (MCTD), Mooren's ulcer, Mucha-Habermann disease, Multiple sclerosis, Myasthenia gravis, Myos
  • Pernicious anemia POEMS syndrome, Polyarteritis nodosa, Type I, II, & III autoimmune polyglandular syndromes, Polymyalgia rheumatica, Polymyositis, Postmyocardial infarction syndrome, Postpericardiotomy syndrome, Progesterone dermatitis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Psoriasis, Psoriatic arthritis, Idiopathic pulmonary fibrosis, Pyoderma gangrenosum, Pure red cell aplasia, Raynauds phenomenon, Reactive Arthritis, Reflex sympathetic dystrophy, Reiter's syndrome, Relapsing polychondritis, Restless legs syndrome, Retroperitoneal fibrosis, Rheumatic fever, Rheumatoid arthritis, Sarcoidosis, Schmidt syndrome, Scleritis, Scleroderma, Sjogren's syndrome, Sperm & testicular autoimmunity,
  • inflammatory disease refers to a disease or condition characterized by aberrant inflammation (e.g. an increased level of inflammation compared to a control such as a healthy person not suffering from a disease).
  • inflammatory diseases include traumatic brain injury, arthritis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, multiple sclerosis, systemic lupus erythematosus (SLE), myasthenia gravis, juvenile onset diabetes, diabetes mellitus type 1 , Guillain-Barre syndrome, Hashimoto's encephalitis, Hashimoto's thyroiditis, ankylosing spondylitis, psoriasis, Sjogren's
  • treating refers to any indicia of success in the therapy or amelioration of an injury, disease, pathology or condition, including any objective or subjective parameter such as abatement; remission; diminishing of symptoms or making the injury, pathology or condition more tolerable to the patient; slowing in the rate of degeneration or decline; making the final point of degeneration less debilitating; improving a patient's physical or mental well-being.
  • the treatment or amelioration of symptoms can be based on objective or subjective parameters; including the results of a physical examination, neuropsychiatric exams, and/or a psychiatric evaluation.
  • the term "treating" and conjugations thereof, may include prevention of an injury, pathology, condition, or disease.
  • treating is preventing.
  • treating does not include preventing.
  • Treating” or “treatment” as used herein also broadly includes any approach for obtaining beneficial or desired results in a subject's condition, including clinical results.
  • beneficial or desired clinical results can include, but are not limited to, alleviation or amelioration of one or more symptoms or conditions, diminishment of the extent of a disease, stabilizing (i.e. , not worsening) the state of disease, prevention of a disease's transmission or spread, delay or slowing of disease progression, amelioration or palliation of the disease state, diminishment of the reoccurrence of disease, and remission, whether partial or total and whether detectable or undetectable.
  • treatment includes any cure, amelioration, or prevention of a disease. Treatment may prevent the disease from occurring; inhibit the disease's spread; relieve the disease's symptoms (e.g., ocular pain, seeing halos around lights, red eye, very high intraocular pressure), fully or partially remove the disease's underlying cause, shorten a disease's duration, or do a combination of these things.
  • the disease's symptoms e.g., ocular pain, seeing halos around lights, red eye, very high intraocular pressure
  • Treating” and “treatment” as used herein include prophylactic treatment.
  • Treatment methods include administering to a subject a therapeutically effective amount of a compound described herein.
  • the administering step may consist of a single administration or may include a series of administrations.
  • the length of the treatment period depends on a variety of factors, such as the severity of the condition, the age of the patient, the concentration of the compound, the activity of the compositions used in the treatment, or a combination thereof.
  • the effective dosage of an agent used for the treatment or prophylaxis may increase or decrease over the course of a particular treatment or prophylaxis regime. Changes in dosage may result and become apparent by standard diagnostic assays known in the art. In some instances, chronic administration may be required.
  • the compositions are administered to the subject in an amount and for a duration sufficient to treat the patient.
  • prevent refers to a decrease in the occurrence of disease symptoms in a patient. As indicated above, the prevention may be complete (no detectable symptoms) or partial, such that fewer symptoms are observed than would likely occur absent treatment. In embodiments, prevent refers to slowing the progression of the disease, disorder or condition or inhibiting progression thereof to a harmful or otherwise undesired state.
  • Patient or “subject in need thereof refers to a living organism suffering from or prone to a disease or condition that can be treated by administration of a pharmaceutical composition as provided herein.
  • Non-limiting examples include humans, other mammals, bovines, rats, mice, dogs, monkeys, goat, sheep, cows, deer, and other non-mammalian animals.
  • a patient is human.
  • an "effective amount” is an amount sufficient for a compound to accomplish a stated purpose relative to the absence of the compound (e.g. achieve the effect for which it is administered, treat a disease, reduce enzyme activity, increase enzyme activity, reduce a signaling pathway, or reduce one or more symptoms of a disease or condition).
  • An example of an "effective amount” is an amount sufficient to contribute to the treatment, prevention, or reduction of a symptom or symptoms of a disease, which could also be referred to as a
  • a “reduction” of a symptom or symptoms means decreasing of the severity or frequency of the symptom(s), or elimination of the symptom(s).
  • a “prophylactically effective amount” of a drug is an amount of a drug that, when administered to a subject, will have the intended prophylactic effect, e.g., preventing or delaying the onset (or reoccurrence) of an injury, disease, pathology or condition, or reducing the likelihood of the onset (or reoccurrence) of an injury, disease, pathology, or condition, or their symptoms.
  • the full prophylactic effect does not necessarily occur by administration of one dose, and may occur only after administration of a series of doses.
  • a prophylactically effective amount may be administered in one or more administrations.
  • An “activity decreasing amount,” as used herein, refers to an amount of antagonist required to decrease the activity of an enzyme relative to the absence of the antagonist.
  • a “function disrupting amount,” as used herein, refers to the amount of antagonist required to disrupt the function of an enzyme or protein relative to the absence of the antagonist. The exact amounts will depend on the purpose of the treatment, and will be ascertainable by one skilled in the art using known techniques (see, e.g. , Lieberman, Pharmaceutical Dosage Forms (vols.).
  • the therapeutically effective amount can be ascertained by measuring relevant physiological effects, and it can be adjusted in connection with the dosing regimen and diagnostic analysis of the subject's condition, and the like.
  • measurement of the serum level of a CCR4 inhibitor (or, e.g., a metabolite thereof) at a particular time post-administration may be indicative of whether a therapeutically effective amount has been administered.
  • the therapeutically effective amount can be initially determined from cell culture assays.
  • Target concentrations will be those concentrations of active compound(s) that are capable of achieving the methods described herein, as measured using the methods described herein or known in the art.
  • therapeutically effective amounts for use in humans can also be determined from animal models.
  • a dose for humans can be formulated to achieve a concentration that has been found to be effective in animals.
  • the dosage in humans can be adjusted by monitoring compounds effectiveness and adjusting the dosage upwards or downwards, as described above. Adjusting the dose to achieve maximal efficacy in humans based on the methods described above and other methods is well within the capabilities of the ordinarily skilled artisan. Adjusting the dose to achieve maximal therapeutic window efficacy or toxicity in humans based on the methods described above and other methods is well within the capabilities of the ordinarily skilled artisan.
  • a therapeutically effective amount refers to that amount of the therapeutic agent sufficient to ameliorate the disorder, as described above.
  • a therapeutically effective amount will show an increase or decrease of at least 5%, 10%, 15%, 20%, 25%, 40%, 50%, 60%, 75%, 80%, 90%, or at least 100%.
  • Therapeutic efficacy can also be expressed as "-fold" increase or decrease.
  • a therapeutically effective amount can have at least a 1.2-fold, 1.5-fold, 2-fold, 5-fold, or more effect over a control.
  • Dosages may be varied depending upon the requirements of the patient and the compound being employed.
  • the dose administered to a patient should be sufficient to effect a beneficial therapeutic response in the patient over time.
  • the size of the dose also will be determined by the existence, nature, and extent of any adverse side-effects. Determination of the proper dosage for a particular situation is within the skill of the practitioner. Generally, treatment is initiated with smaller dosages, which are less than the optimum dose of the compound. Thereafter, the dosage is increased by small increments until the optimum effect under circumstances is reached. Dosage amounts and intervals can be adjusted individually to provide levels of the administered compound effective for the particular clinical indication being treated. This will provide a therapeutic regimen that is commensurate with the severity of the individual's disease state.
  • administering means oral administration, administration as a suppository, topical contact, intravenous, intraperitoneal, intramuscular, intralesional, intrathecal, intranasal or subcutaneous administration, or the implantation of a slow-release device, e.g., a mini-osmotic pump, to a subject.
  • Administration is by any route, including parenteral and transmucosal (e.g., buccal, sublingual, palatal, gingival, nasal, vaginal, rectal, or transdermal) compatible with the preparation.
  • Parenteral administration includes, e.g., intravenous, intramuscular, intra-arteriole, intradermal, subcutaneous, intraperitoneal, intraventricular, and intracranial.
  • Other modes of delivery include, but are not limited to, the use of liposomal formulations, intravenous infusion, transdermal patches, etc.
  • administration includes contact (e.g., in vitro or ex vivo) of a compound to the cell, as well as contact of a compound to a fluid, where the fluid is in contact with the cell.
  • compositions described herein are administered at the same time, just prior to, or just after the administration of one or more additional therapies.
  • the compounds of the disclosure can be administered alone or can be coadministered to the patient. Co-administration is meant to include simultaneous or sequential administration of the compounds individually or in combination (more than one compound).
  • the compositions of the present disclosure can be delivered transdermally, by a topical route, or formulated as applicator sticks, solutions, suspensions, emulsions, gels, creams, ointments, pastes, jellies, paints, powders, and aerosols.
  • a "cell” as used herein, refers to a cell carrying out metabolic or other function sufficient to preserve or replicate its genomic DNA.
  • a cell can be identified by well-known methods in the art including, for example, presence of an intact membrane, staining by a particular dye, ability to produce progeny or, in the case of a gamete, ability to combine with a second gamete to produce a viable offspring.
  • Cells may include prokaryotic and eukaroytic cells.
  • Prokaryotic cells include but are not limited to bacteria.
  • Eukaryotic cells include but are not limited to yeast cells and cells derived from plants and animals, for example mammalian, insect (e.g., spodoptera) and human cells. Cells may be useful when they are naturally nonadherent or have been treated not to adhere to surfaces, for example by trypsinization.
  • Control or "control experiment” is used in accordance with its plain ordinary meaning and refers to an experiment in which the subjects or reagents of the experiment are treated as in a parallel experiment except for omission of a procedure, reagent, or variable of the experiment.
  • the control is used as a standard of comparison in evaluating experimental effects.
  • a control is the measurement of the activity of a protein in the absence of a compound as described herein (including embodiments and examples).
  • a CCR4 associated disease modulator is a compound that reduces the severity of one or more symptoms of a disease associated with CCR4 (e.g. cancer, inflammatory disease, autoimmune disease, or infectious disease).
  • a CCR4 modulator is a compound that increases or decreases the activity or function or level of activity or level of function of CCR4.
  • a modulator may act alone, or it may use a cofactor, e.g., a protein, metal ion, or small molecule. Examples of modulators include small molecule compounds and other bioorganic molecules.
  • modulate is used in accordance with its plain ordinary meaning and refers to the act of changing or varying one or more properties. “Modulation” refers to the process of changing or varying one or more properties. For example, as applied to the effects of a modulator on a target protein, to modulate means to change by increasing or decreasing a property or function of the target molecule or the amount of the target molecule.
  • the terms “modulate,” “modulation” and the like refer to the ability of a molecule (e.g., an activator or an inhibitor) to increase or decrease the function or activity of CCR4, either directly or indirectly, relative to the absence of the molecule.
  • a molecule e.g., an activator or an inhibitor
  • a disease e.g., a protein associated disease, a cancer associated with CCR4 activity, CCR4 associated cancer, CCR4 associated disease (e.g., cancer, inflammatory disease, autoimmune disease, or infectious disease)
  • the disease e.g., cancer, inflammatory disease, autoimmune disease, or infectious disease
  • a cancer associated with CCR4 activity or function may be a cancer that results (entirely or partially) from aberrant CCR4 function (e.g.
  • a cancer associated with CCR4 activity or function or a CCR4 associated disease e.g., cancer, inflammatory disease, autoimmune disease, or infectious disease
  • a compound described herein e.g., CCR4 modulator or CCR4 inhibitor
  • an inflammatory disease associated with CCR4 activity or function or an CCR4 associated inflammatory disease may be treated with an CCR4 modulator or CCR4 inhibitor, in the instance where increased CCR4 activity or function (e.g. signaling pathway activity) causes the disease.
  • aberrant refers to different from normal. When used to describe enzymatic activity or protein function, aberrant refers to activity or function that is greater or less than a normal control or the average of normal non-diseased control samples. Aberrant activity may refer to an amount of activity that results in a disease, wherein returning the aberrant activity to a normal or non-disease-associated amount (e.g. by administering a compound or using a method as described herein), results in reduction of the disease or one or more disease symptoms.
  • signaling pathway refers to a series of interactions between cellular and optionally extra-cellular components (e.g., proteins, nucleic acids, small molecules, ions, lipids) that conveys a change in one component to one or more other components, which in turn may convey a change to additional components, which is optionally propogated to other signaling pathway components.
  • extra-cellular components e.g., proteins, nucleic acids, small molecules, ions, lipids
  • binding of a CCR4 with a compound as described herein may reduce the level of a product of the CCR4 catalyzed reaction or the level of a downstream derivative of the product or binding may reduce the interactions between the CCR4 or a reaction product and downstream effectors or signaling pathway components (e.g., MAP kinase pathway), resulting in changes in cell growth, proliferation, or survival.
  • a CCR4 may reduce the level of a product of the CCR4 catalyzed reaction or the level of a downstream derivative of the product or binding by the interactions between the CCR4 or a reaction product and downstream effectors or signaling pathway components (e.g., MAP kinase pathway), resulting in changes in cell growth, proliferation, or survival.
  • downstream effectors or signaling pathway components e.g., MAP kinase pathway
  • CCR4 inhibitor refers to a compound capable of modulating, either directly or indirectly, the CCR4 receptor in an in vitro assay, an in vivo model, and/or other means indicative of therapeutic efficacy.
  • CCR4 antagonist refers to a compound capable of modulating, either directly or indirectly, the CCR4 receptor in an in vitro assay, an in vivo model, and/or other means indicative of therapeutic efficacy.
  • the terms also refer to a compound that exhibits at least some therapeutic benefit in a human subject.
  • the phrase "in a sufficient amount to effect a change” means that there is a detectable difference between a level of an indicator measured before (e.g., a baseline level) and after administration of a particular therapy.
  • Indicators include any objective parameter (e.g., serum concentration) or subjective parameter (e.g., a subject's feeling of well-being).
  • the "activity" of a molecule may describe or refer to the binding of the molecule to a ligand or to a receptor; to catalytic activity; to the ability to stimulate gene expression or cell signaling, differentiation, or maturation; to antigenic activity; to the modulation of activities of other molecules; and the like.
  • the term "proliferative activity” encompasses an activity that promotes, that is necessary for, or that is specifically associated with, for example, normal cell division, as well as cancer, tumors, dysplasia, cell transformation, metastasis, and angiogenesis.
  • substantially pure indicates that a component makes up greater than about 50% of the total content of the composition, and typically greater than about 60% of the total polypeptide content. More typically, “substantially pure” refers to compositions in which at least 75%, at least 85%, at least 90% or more of the total composition is the component of interest. In some cases, the polypeptide will make up greater than about 90%, or greater than about 95% of the total content of the composition (percentage in a weight per weight basis).
  • ligand/receptor, antibody/antigen, or other binding pair indicates a binding reaction which is determinative of the presence of the protein in a heterogeneous population of proteins and other biologies.
  • a specified ligand binds to a particular receptor and does not bind in a significant amount to other proteins present in the sample.
  • the antibody, or binding composition derived from the antigen-binding site of an antibody, of the contemplated method binds to its antigen, or a variant or mutein thereof, with an affinity that is at least twofold greater, at least 10-times greater, at least 20-times greater, or at least 100-times greater than the affinity with any other antibody, or binding composition derived therefrom.
  • the antibody will have an affinity that is greater than about 10 9 liters/mol, as determined by, e.g., Scatchard analysis (Munsen, et al. (1980) Analyt. Biochem. 107:220-239).
  • DNA DNA
  • nucleic acid nucleic acid molecule
  • polynucleotide polynucleotide
  • mRNA messenger RNA
  • cDNA complementary DNA
  • vectors vectors, probes, primers and the like.
  • variants are used interchangeably to refer to amino acid or nucleic acid sequences that are similar to reference amino acid or nucleic acid sequences, respectively.
  • the term encompasses naturally-occurring variants and non-naturally- occurring variants.
  • Naturally-occurring variants include homologs (polypeptides and nucleic acids that differ in amino acid or nucleotide sequence, respectively, from one species to another), and allelic variants (polypeptides and nucleic acids that differ in amino acid or nucleotide sequence, respectively, from one individual to another within a species).
  • variants and homologs encompass naturally occurring amino acid and nucleic acid sequences encoded thereby and their isoforms, as well as splice variants of a protein or gene.
  • the terms also encompass nucleic acid sequences that vary in one or more bases from a naturally-occurring nucleic acid sequence but still translate into an amino acid sequence that corresponds to the naturally-occurring protein due to degeneracy of the genetic code.
  • Non-naturally-occurring variants and homologs include polypeptides and nucleic acids that comprise a change in amino acid or nucleotide sequence, respectively, where the change in sequence is artificially introduced (e.g., muteins); for example, the change is generated in the laboratory by human intervention ("hand of man”). Therefore, non-naturally occurring variants and homologs may also refer to those that differ from the naturally-occurring sequences by one or more conservative
  • muteins refers broadly to mutated recombinant proteins. These proteins usually carry single or multiple amino acid substitutions and are frequently derived from cloned genes that have been subjected to site-directed or random mutagenesis, or from completely synthetic genes.
  • R 1 is hydrogen, halogen, -
  • R 3 unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • R 5 is independently hydrogen
  • R 17 unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • substituted or unsubstituted alkyl substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.
  • X 1 , X 2 and X 3 is N.
  • the symbols nl , n2, n3, n4, n5, n6, n8, n9, nlO, nl 1 , and nl7 are independently an integer from 0 to 4.
  • the symbols ml , m2, m3, m4, m5, m6, m8, m9, mlO, ml 1 , ml7, vl , v2, v3, v4, v5, v6, v8, v9, vlO, vl 1 , and vl7 are independently 1 or 2.
  • the symbol zl is an integer from 0 to 5.
  • the symbol z2 is an integer from 0 to 8.
  • the symbol z3 is an integer from 0 to 12.
  • A is a substituted or unsubstituted cycloalkyl. In embodiments, A is a substituted or unsubstituted heterocycloalkyl.
  • A is 4- to 8-membered substituted or unsubstituted heterocycloalkyl. In embodiments, A is 4-membered substituted or unsubstituted heterocycloalkyl. In embodiments, A is 4-membered substituted or unsubstituted heterocycloalkyl.
  • A is 5-membered substituted or unsubstituted heterocycloalkyl. In embodiments, A is 6-membered substituted or unsubstituted heterocycloalkyl. In embodiments, A is 7- membered substituted or unsubstituted heterocycloalkyl. In embodiments, A is 8-membered substituted or unsubstituted heterocycloalkyl.
  • X 1 is CR 8 or N. In embodiments, X 1 is CR 8 . In embodiments, X 1 is N.
  • X 2 is CR 9 or N. In embodiments, X 2 is CR 9 . In embodiments, X 2 is N.
  • X 3 is CR 10 or N. In embodiments, X 3 is CR 10 . In embodiments, X 3 is N. [0110] In embodiments, X 4 is C, CR 11 or . In embodiments, X 4 is C. In embodiments, X 4 is CR 11 . In embodiments, X 4 is N.
  • X 7 is NR 17 or N. In embodiments, X 7 is NR 17 . In embodiments, X 7 is N.
  • X 1 , X 2 and X 3 are N.
  • X 1 is N.
  • X 2 is N.
  • X 3 is N.
  • X 1 and X 2 are independently N.
  • X 1 and X 3 are independently N.
  • X 2 and X 3 are independently N.
  • X 4 is CR 11 or N. In embodiments, is a
  • X 4 is CR 11 . In embodiments, is a single bond and X 4 is N. In
  • L 7 is a bond, -0-, -S-, -NR 7B -, -C(O)-, -C(0)0-, -S(O) -, -S(0) 2 -, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene.
  • L 7 is a bond, -0-, -S-, -NR 7B -, -C(O)-, -C(0)0-, -S(O) -, -S(0) 2 -, substituted or unsubstituted alkylene (e.g., C 1 -C 8 alkylene, C 1 -C 6 alkylene, or C 1 -C4 alkylene), substituted or unsubstituted heteroalkylene (e.g., 2 to 8 membered heteroalkylene, 2 to 6 membered heteroalkylene, or 2 to 4 membered heteroalkylene), substituted or unsubstituted cycloalkylene (e.g., C 3 -C 8 cycloalkylene, C 3 -C6 cycloalkylene, or C5-C6 cycloalkylene), substituted or unsubstituted heterocycloalkylene (e.g., 3 to 8 membered heterocycloalkylene (e.g
  • heteroarylene or 5 to 6 membered heteroarylene.
  • L 7 is a bond
  • R 58 -substituted or unsubstituted alkylene e.g., C 1 -C 8 alkylene, C 1 -C 6 alkylene, or C 1 -C4 alkylene
  • R 58 -substituted or unsubstituted heteroalkylene e.g., 2 to 8 membered heteroalkylene, 2 to 6 membered heteroalkylene, or 2 to 4 membered heteroalkylene
  • R -substituted or unsubstituted cycloalkylene e.g., C 3 -C 8 cycloalkylene, C 3 -C6 cycloalkylene, or C5-C6 cycloalkylene
  • R 58 -substituted or unsubstituted heterocycloalkylene e.g., 3 to 8 membered heterocycloalkylene, 3 to 6 membered heterocycloalkylene, or 5 to 6 membered
  • R 58 -substituted or unsubstituted arylene e.g., C 6 -C10 arylene, C10 arylene, or phenylene
  • R 58 -substituted or unsubstituted heteroarylene e.g., 5 to 10 membered heteroarylene, 5 to 9 membered heteroarylene, or 5 to 6 membered heteroarylene.
  • L 7 is R 58 -substituted or unsubstituted alkylene (e.g., C 1 -C 8 alkylene, C 1 -C 6 alkylene, or C 1 -C4 alkylene). In embodiments, L 7 is R 58 -substituted alkylene (e.g., C 1 -C 8 alkylene, C 1 -C 6 alkylene, or C 1 -C4 alkylene). In embodiments, L 7 is an unsubstituted alkylene (e.g., C 1 -C 8 alkylene, C 1 -C 6 alkylene, or C 1 -C4 alkylene).
  • L 7 is R 58 -substituted or unsubstituted heteroalkylene (e.g., 2 to 8 membered heteroalkylene, 2 to 6 membered heteroalkylene, or 2 to 4 membered heteroalkylene).
  • L 7 is R 58 -substituted heteroalkylene (e.g., 2 to 8 membered heteroalkylene, 2 to 6 membered heteroalkylene, or 2 to 4 membered heteroalkylene).
  • L 7 is an unsubstituted heteroalkylene (e.g., 2 to 8 membered heteroalkylene, 2 to 6 membered
  • heteroalkylene or 2 to 4 membered heteroalkylene.
  • L 7 is R 58 -substituted or unsubstituted cycloalkylene (e.g., C 3 -C 8 cycloalkylene, C 3 -C6 cycloalkylene, or C5-C6 cycloalkylene).
  • L 7 is R 58 - substituted cycloalkylene (e.g., C 3 -C 8 cycloalkylene, C 3 -C6 cycloalkylene, or C5-C6
  • L 7 is an unsubstituted cycloalkylene (e.g., C 3 -C 8 cycloalkylene, C 3 -C6 cycloalkylene, or C5-C6 cycloalkylene).
  • L 7 is R 58 -substituted or unsubstituted heterocycloalkylene (e.g., 3 to 8 membered heterocycloalkylene, 3 to 6 membered heterocycloalkylene, or 5 to 6 membered heterocycloalkylene).
  • L 7 is R 58 -substituted heterocycloalkylene (e.g., 3 to 8 membered heterocycloalkylene, 3 to 6 membered heterocycloalkylene, or 5 to 6 membered heterocycloalkylene).
  • L 7 is an unsubstituted heterocycloalkylene (e.g., 3 to 8 membered heterocycloalkylene, 3 to 6 membered heterocycloalkylene, or 5 to 6 membered heterocycloalkylene).
  • L 7 is R 58 -substituted or unsubstituted arylene (e.g., C 6 -C10 arylene, C10 arylene, or phenylene).
  • L 7 is R 58 -substituted arylene (e.g., C 6 -C10 arylene, C10 arylene, or phenylene).
  • L 7 is an unsubstituted arylene (e.g., C 6 -C10 arylene, C10 arylene, or phenylene).
  • L 7 is R 58 -substituted or unsubstituted heteroarylene (e.g., 5 to 10 membered heteroarylene, 5 to 9 membered heteroarylene, or 5 to 6 membered heteroarylene). In embodiments, L 7 is R 58 -substituted heteroarylene (e.g., 5 to 10 membered heteroarylene, 5 to 9 membered heteroarylene, or 5 to 6 membered heteroarylene). In embodiments, L 7 is an unsubstituted heteroarylene (e.g., 5 to 10 membered heteroarylene, 5 to 9 membered
  • heteroarylene or 5 to 6 membered heteroarylene.
  • L 7 is a bond. In embodiments, L 7 is substituted or unsubstituted alkylene.
  • R 58 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • -NHC(0)NH 2 -NHSO2H, -NHC(0)H, -NHC(0)OH, -NHOH, -OCCl 3 , -OCF 3 , -OCBr 3 , -OCI 3 ,-OCHCl 2 , -OCHBr 2 , -OCHI2, -OCHF2, substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), substituted or un
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 1 is hydrogen, halogen, -CX L1 3 , -CHX L 1 2 , -CH2X 1 1 , -CN, -
  • substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 59 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 59 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 59 -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 1 is R 59 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 1 is R 59 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 1 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 1 is R 59 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 1 is R 59 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 1 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 1 is R 59 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 1 is R 59 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 1 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 1 is R 59 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 1 is R 59 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 1 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 1 is R 59 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 1 is R 59 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 1 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 1 is R 59 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 1 is R 59 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 1 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 1 is hydrogen, substituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. In embodiments, R 1 is hydrogen or unsubstituted alkyl. In embodiments, R 1 is H, CH 3 or -CH2CH3. In embodiments, R 1 is hydrogen.
  • R 2 is hydrogen, halogen, -CX 2 1 3 , -CHX 2 1 2 , -CH 2 X 2 1 , -CN, - SOTON 2 R 2A , SOv 2 NR 2B R 2C , -NHNR 2B R 2C , -ONR 2B R 2C , -NHC(0)NHNR 2B R 2C ,
  • R 2 is R 19 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 2 is R 19 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 2 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 2 is an unsubstituted ethyl. In embodiments, R 2 is an unsubstituted C 3 alkyl. In embodiments, R 2 is an unsubstituted C4 alkyl. [0135] In embodiments, R 2 is R 19 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 2 is R 19 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 2 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 2 is R 19 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 2 is R 19 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 2 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 2 is R 19 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 2 is R 19 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 2 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 2 is R 19 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 2 is R 19 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 2 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 2 is R 19 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 2 is R 19 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 2 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 2 is hydrogen, substituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl. In embodiments, R 2 is hydrogen or unsubstituted alkyl.
  • R 2 is H, -CH3 or -CH2CH3. In embodiments, R 2 is hydrogen. [0141] In embodiments, R 3 is hydrogen, halogen, -CX 3.1 3 , -CHX 3.1 2 , -CH 2 X 3.1 , -CN, -
  • R 22 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 22 - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 22 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 22 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 3 is halogen, -CX 3.1 3 , -CHX 3.1 2 , -CH 2 X 3.1 , -CN, -SOlement 3 R 3A , -
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 22 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 22 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 22 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 3 is R 22 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 3 is R 22 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 3 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 3 is R 22 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 3 is R 22 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 3 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 3 is R 22 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 3 is R 22 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 3 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 3 is R 22 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 3 is R 22 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 3 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 3 is R 22 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 3 is R 22 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 3 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 3 is R 22 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 3 is R 22 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 3 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 3 is assumed by R 3 2 and R 3 3 .
  • R 4 is halogen, -CX 4.1 3 , -CHX 4.1 2 , -CH 2 X 4.1 , -CN, -SOlement 4 R 4A , -
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 25 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 25 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 25 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 4 is R 25 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 4 is R 25 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 4 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 4 is an unsubstituted ethyl. In embodiments, R 4 is an unsubstituted C3 alkyl. In embodiments, R 4 is an unsubstituted C4 alkyl.
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -
  • R 4 is R 25 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 4 is R 25 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 4 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 4 is R 25 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 4 is R 25 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 4 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C5 cycloalkyl, or C5-C6 cycloalkyl).
  • R 4 is R 25 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 4 is R 25 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 4 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 4 is R 25 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 4 is R 25 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 4 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 4 is R 25 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 4 is R 25 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 4 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 4 is hydrogen, -CN, -CX 4.1 3 , -C(0)R 4D , -C(0)OR 4D , - C(0)NR 4B R 4C , substituted or unsubstituted alkyl or substituted or unsubstituted heteroalkyl.
  • R 4 is H, -CN, -CF 3 , -C(0)NH 2 , -CH 3 or -C(0)OCH 2 CH 3 .
  • R 5 is hydrogen, halogen, -CX 5 1 3 , -CHX 5 1 2 , -CH 2 X 5 1 , -CN, - SOTON 5 R 5A ,
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 28 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 28 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 28 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 28 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 28 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 28 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 5 is R 28 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 5 is R 28 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 5 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 5 is R 28 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 5 is R 28 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 5 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 5 is R 28 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 5 is R 28 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 5 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 5 is R 28 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 5 is R 28 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 5 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 5 is R 28 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 5 is R 28 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 5 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 5 is R 28 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 5 is R 28 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 5 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 5 is hydrogen, fluorine, -CN, -CH 3 , -CF 3 , -(CH 2 )OH, -(CH 2 ) 2 OH, -C0 2 NH 2 or -C0 2 CH 2 CH 3 .
  • R 6 is hydrogen, halogen, -CX 6 1 3 , -CHX 6 1 2 , -CH 2 X 6 1 , -CN, -
  • R 31 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 31 - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 31 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 31 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 6 is halogen, -CX 6 1 3 , -CHX 6 1 2 , -CH 2 X 6 1 , -CN, -SO estate 6 R 6A , -
  • alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 31 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 31 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 31 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 6 is R 31 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 6 is R 31 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 6 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 6 is R 31 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 6 is R 31 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 6 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 6 is R 31 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 6 is R 31 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 6 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 6 is R 31 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 6 is R 31 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 6 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 6 is R 31 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 6 is R 31 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 6 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 6 is R 31 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 6 is R 31 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 6 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 6 is hydrogen, -OH, -CH 3 , -NH 2 , -CH 2 OH, or -(CH 2 ) 2 C0 2 H.
  • R 8 is hydrogen, halogen, -CX 8 1 3 , -CHX 8 1 2 , -CH 2 X 8 1 , -CN, -
  • R 34 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 34 - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 34 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 34 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 8 is R 34 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 8 is R 34 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 8 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). [0179] In embodiments, R 8 is R 34 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8
  • R 8 is R 34 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 8 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 8 is R 34 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 8 is R 34 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 8 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 8 is R 34 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 8 is R 34 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 8 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 8 is R 34 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 8 is R 34 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 8 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 8 is R 34 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 8 is R 34 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 8 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 9 is hydrogen, halogen, -CX 9. 1 3 , -CHX 9. 1 2 , -CH 2 X 9. 1 , -CN, -
  • R 37 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 37 - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 37 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 37 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 9 is R 37 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 9 is R 37 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 9 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 9 is R 37 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 9 is R 37 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 9 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 9 is R 37 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 9 is R 37 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 9 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C5 cycloalkyl, or C5-C6 cycloalkyl).
  • R 9 is R 37 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 9 is R 37 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 9 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl).
  • R 9 is R 37 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 9 is R 37 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 9 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 9 is R 37 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 9 is R 37 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 9 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 10 is hydrogen, halogen, -CX 10 1 3 , -CHX 10 1 2 , -CH 2 X 10 1 , -CN, -
  • R 40 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 40 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 40 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl
  • R 40 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl
  • R 10 is R 40 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 10 is R 40 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 10 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 10 is R 40 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 10 is R 40 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 10 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 10 is R 40 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 10 is R 40 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl.
  • R 10 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 10 is R 40 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 10 is R 40 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 10 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 10 is R 40 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 10 is R 40 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 10 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 10 is R 40 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 10 is R 40 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 10 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 11 is hydrogen, halogen, -CX 1 1.1 3 , -CHX 1 1.1 2 , -CH 2 X 1 1.1 , -CN, -
  • R 43 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 43 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 43 -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 11 is R 43 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 11 is R 43 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 11 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 11 is R 43 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 11 is R 43 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 11 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 11 is R 43 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 11 is R 43 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 11 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 11 is R 43 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 11 is R 43 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 11 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 11 is R 43 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 11 is R 43 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 1 1 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 11 is R 43 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 11 is R 43 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 11 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 17 is hydrogen, halogen, -CX 17 1 3 , -CHX 17 1 2 , -CH 2 X 17 1 , -CN,
  • R 65 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -Ce alkyl, or C 1 -C 4 alkyl
  • R 65 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 65 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl
  • R 65 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 17 is R 65 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 17 is R 65 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 17 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 17 is R 65 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 17 is R 65 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 17 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 17 is R 65 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 17 is R 65 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 17 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 17 is R 65 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 17 is R 65 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 17 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 17 is R 65 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 17 is R 65 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 17 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 17 is R 65 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 17 is R 65 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 17 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 10B , R 10C , R 10D , R 11A , R 11B , R 11C , R 11D , R 17A , R 17B , R 17C and R 17D are independently hydrogen, halogen, substituted or unsubstituted alkyl,
  • substituted or unsubstituted heteroalkyl substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • R 1B and R 1C , R 2B and R 2C , R 3B and R 3C , R 4B and R 4C , R 5B and R 5C , R 6B and R 6C , R 8B and R 8C , R 9B and R 9C , R 10B and R 10C , R 11B and R 11C and R 17B and R 17C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.
  • R 1A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 59A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 59A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 59A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 59A -substituted or
  • R 2A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 19A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 19A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 19A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 19A -substituted or unsubstituted or unsubstit
  • R 3A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 22A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 22A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 22A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 22A -substituted or unsubstituted or unsubstit
  • R 4A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 25A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 25A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 25A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 25A -substituted or unsubstituted or unsubstit
  • R 5A is hydrogen, halogen, -CF 3 , -CCl 3 , -CBr 3 , -CI 3 ,-COOH, -CONH2, R 28A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 28A - substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 28A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 28A -substituted or unsubstituted heterokyl (e.g.
  • R 6A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 31A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 31A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 31A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl), R 31A -substituted or unsubstituted or unsubstit
  • R 8A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 34A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 34A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 34A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 34A -substituted or unsubstituted or unsubstit
  • R 9A is hydrogen, halogen, -CF 3 , -CCl 3 , -CBr 3 , -CI 3 ,-COOH, -CONH2, R 37A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 37A - substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 37A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 37A -substituted or unsubstituted heteroalkyl (e.g
  • R 10A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 40A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 40A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 40A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl), R 40A -substituted or unsubstituted alkyl (e
  • R 11A is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 43A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 43A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 43A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 43A -substituted or unsubstituted or unsubstituted
  • R 17A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 65A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 65A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 65A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 65A -substituted or unsubstituted or unsubstit
  • R 1B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 59B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 59B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 59B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 59B -substituted or
  • R 1B and R 1C substituents bonded to the same nitrogen atom may optionally be joined to form a R 59B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 59B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R -substituted or unsubstituted heteroaryl e.g., 5 to
  • R 2B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 19B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 19B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 19B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 19B -substituted or unsubstituted or unsubstit
  • R 2B and R 2C substituents bonded to the same nitrogen atom may optionally be joined to form a R 19B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 19B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 19B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 19B -substituted or unsubstituted heteroaryl e.g.,
  • R 3B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 22B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 22B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 22B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 22B -substituted or unsubstituted or unsubstit
  • R 3B and R 3C substituents bonded to the same nitrogen atom may optionally be joined to form a R 22B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 22B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 22B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 22B -substituted or unsubstituted heteroaryl e.g.,
  • R 4B is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 25B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 25B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 25B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 25B -substituted or unsubstituted or unsubstituted
  • R 4B and R 4C substituents bonded to the same nitrogen atom may optionally be joined to form a R 25B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 25B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 25B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 25B -substituted or unsubstituted heteroaryl e.g.,
  • R 5B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 28B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 28B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 28B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 28B -substituted or unsubstituted or unsubstit
  • R 5B and R 5C substituents bonded to the same nitrogen atom may optionally be joined to form a R 28B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 28B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 28B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 28B -substituted or unsubstituted heteroaryl e.g.,
  • R 6B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 31B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 31B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 31B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R 31B -substituted or unsubstituted or unsubstit
  • R 6B and R 6C substituents bonded to the same nitrogen atom may optionally be joined to form a R 31B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 31B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 31B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 31B -substituted or unsubstituted heteroaryl e.g.,
  • R 7B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 58B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 58B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 58B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 58B -substituted or
  • R 7B and R 7C substituents bonded to the same nitrogen atom may optionally be joined to form a R 58B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 58B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 58B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 58B -substituted or unsubstituted heteroaryl e
  • R 8B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 34B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 34B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 34B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R -substituted or unsubstituted or unsubstituted
  • R 8B and R 8C substituents bonded to the same nitrogen atom may optionally be joined to form a R 34B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 34B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 34B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 34B -substituted or unsubstituted heteroaryl e.g.,
  • R 9B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 37B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 37B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 37B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 37B -substituted or unsubstituted or unsubstit
  • R 9B and R 9C substituents bonded to the same nitrogen atom may optionally be joined to form a R 37B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 37B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 37B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 37B -substituted or unsubstituted heteroaryl e.g.,
  • R 10B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 40B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 40B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 40B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 40B -substituted or unsubstituted or unsubstit
  • R 10B and R 10C substituents bonded to the same nitrogen atom may optionally be joined to form a R 40B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 40B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 40B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 40B -substituted or unsubstituted heteroaryl e.g.,
  • R 11B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 43B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 43B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 43B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 43B -substituted or unsubstituted or unsubstit
  • R 11B and R 11C substituents bonded to the same nitrogen atom may optionally be joined to form a R 43B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 43B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 43B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 43B -substituted or unsubstituted heteroaryl e.g.,
  • R 11B and R 11C substituents bonded to the same nitrogen atom may optionally be joined to form a R 43B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 43B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 43B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 43B -substituted or unsubstituted heteroaryl e.g.,
  • R 17B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 65B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 65B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 65B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R -substituted or unsubstituted or unsubstituted
  • R 17B and R 17C substituents bonded to the same nitrogen atom may optionally be joined to form a R 65B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 65B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 65B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 65B -substituted or unsubstituted heteroaryl e.g.,
  • R 17B and R 17C substituents bonded to the same nitrogen atom may optionally be joined to form a R 65B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 65B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 65B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 65B -substituted or unsubstituted heteroaryl e.g.,
  • R 1C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 59C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 59C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 59C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 59C -substituted or
  • R 1B and R 1C substituents bonded to the same nitrogen atom may optionally be joined to form a R 59C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 59C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 59C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 59C -substituted or unsubstituted heteroaryl e
  • R 2C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 19C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 19C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R 19C -substituted or unsubstituted or unsubstituted
  • R 2B and R 2C substituents bonded to the same nitrogen atom may optionally be joined to form a R 19C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 19C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 19C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 19C -substituted or unsubstituted heteroaryl e.g.,
  • R 3C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 22C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 22C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 22C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 22C -substituted or unsubstituted or unsubstit
  • R 3B and R 3C substituents bonded to the same nitrogen atom may optionally be joined to form a R 22C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 22C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 22C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 22C -substituted or unsubstituted heteroaryl e.g.,
  • R 4C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 25C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 25C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 25C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R -substituted or unsubstituted or unsubstituted
  • R 4B and R 4C substituents bonded to the same nitrogen atom may optionally be joined to form a R 25C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 25C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 25C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 25C -substituted or unsubstituted heteroaryl e.g.,
  • R 5C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 28C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 28C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 28C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 28C -substituted or unsubstituted or unsubstit
  • R 5B and R 5C substituents bonded to the same nitrogen atom may optionally be joined to form a R 28C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 28C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 28C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 28C -substituted or unsubstituted heteroaryl e.g.,
  • R 6C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 31c -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 31c -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 31c -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 31c -substituted or unsubstituted or unsubstit
  • R 6B and R 6C substituents bonded to the same nitrogen atom may optionally be joined to form a R 31c -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 31c -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 31c -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 31c -substituted or unsubstituted heteroaryl e.g.,
  • R 8C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 34C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl), R 34C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 34C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 34C -substituted or unsubstituted or unsubstit
  • R 8B and R 8C substituents bonded to the same nitrogen atom may optionally be joined to form a R 34C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 34C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 34C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 34C -substituted or unsubstituted heteroaryl e.g.,
  • R 9C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 37C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl), R 37C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 37C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 37C -substituted or unsubstituted or unsubstit
  • R 9B and R 9C substituents bonded to the same nitrogen atom may optionally be joined to form a R 37C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 37C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 37C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 37C -substituted or unsubstituted heteroaryl e.g.,
  • R 10C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 40C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 40C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 40C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 40C -substituted or unsubstituted or unsubstit
  • R 10B and R 10C substituents bonded to the same nitrogen atom may optionally be joined to form a R 40B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 40B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 40B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 40B -substituted or unsubstituted heteroaryl e.g.,
  • R 11C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 43C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 43C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 43C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 43C -substituted or unsubstituted or unsubstit
  • R 11B and R 11C substituents bonded to the same nitrogen atom may optionally be joined to form a R 43C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 43C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 43C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 43C -substituted or unsubstituted heteroaryl e.g.,
  • R 17C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 65C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 65C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 65C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 65C -substituted or unsubstituted or unsubstit
  • R 17B and R 17C substituents bonded to the same nitrogen atom may optionally be joined to form a R 65C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 65C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 65C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 65C -substituted or unsubstituted heteroaryl e.g.,
  • R 1D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 59D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 59D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 59D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 59D -substituted or
  • R 2D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, -
  • R 19D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl),
  • R 19D -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 19D -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 19D -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 19D -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 3D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 22D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 22D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 22D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 22D -substituted or unsubstituted or unsubstit
  • R 4D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 25D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 25D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 25D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 25D -substituted or unsubstituted or unsubstit
  • R 5D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, -
  • R 28D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl),
  • R 28D -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 28D -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 28D -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 28D -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 6D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 31D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 31D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 31D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 31D -substituted or unsubstituted or unsubstit
  • R 8D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 34D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 34D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 34D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 34D -substituted or unsubstituted or unsubstit
  • R 9D is hydrogen, halogen, -CF 3 , -CCl 3 , -CBr 3 , -CI 3 ,-COOH, -CONH2,
  • R 37D -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 37D - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 37D -substituted or unsubstituted cycloalkyl e.g.,
  • R 37D -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 37D -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 10D is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 40D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 40D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 40D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 40D -substituted or unsubstituted or unsubstituted
  • R 11D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 43D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 43D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 43D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 43D -substituted or unsubstituted or unsubstit
  • R 17D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 65D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 65D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 65D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 65D -substituted or unsubstituted or unsubstit
  • R 19 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 , -NHC(0)NH 2 , -NHS0 2 H, -NHC(0)H, -NHC(0)OH, -NHOH, -OCCI3, -OCF3, -OCBr 3 , -OCI 3 ,-OCHCl 2 , -OCHBr 2 , -OCHI 2 , -OCHF 2 , R 20 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 20 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 20 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 19 is R 20 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 19 is R 20 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 19 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 19 is R 20 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 19 is R 20 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 19 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 19 is R 20 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 19 is R 20 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 19 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 19 is R 20 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 19 is R 20 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 19 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 19 is R 20 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 19 is R 20 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 19 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 19 is R 20 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 19 is R 20 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 19 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 20 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 21 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 21 - substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 21 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 21 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl
  • R 20 is R 21 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 20 is R 21 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 20 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 20 is R 21 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 20 is R 21 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 20 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 20 is R 21 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 20 is R 21 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 20 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 20 is R 21 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 20 is R 21 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 20 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 20 is R 21 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 20 is R 21 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 20 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 20 is R 21 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 20 is R 21 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 20 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 21 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH,
  • unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -Ce alkyl, or C 1 -C4 alkyl
  • unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • unsubstituted aryl e.
  • R 22 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 23 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 23 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 23 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 23 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 23 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 22 is R 23 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 22 is R 23 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 22 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 22 is R 23 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 22 is R 23 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 22 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 22 is R 23 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 22 is R 23 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 22 is R 23 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 22 is R 23 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 22 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 22 is R 23 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 22 is R 23 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 22 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 22 is R 23 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 22 is R 23 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 22 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 23 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -SO3H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 24 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 24 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 24 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 24 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 24 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 23 is R 24 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 23 is R 24 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 23 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 23 is R 24 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 23 is R 24 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 23 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 23 is R 24 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 23 is R 24 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl.
  • R 23 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 23 is R 24 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 23 is R 24 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 23 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 23 is R 24 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 23 is R 24 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 23 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 23 is R 24 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R is R -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 23 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 24 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 25 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NH H2, -ONH2, -NHC(0)NH H 2 ,
  • R 26 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 26 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 26 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 26 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 26 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 25 is R 26 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 25 is R 26 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 25 is R 26 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 25 is R 26 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 25 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 25 is R 26 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 25 is R 26 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 25 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 25 is R 26 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 25 is R 26 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 25 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 25 is R 26 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 25 is R 26 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 25 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 25 is R 26 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 25 is R 26 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 25 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 27 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 27 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 27 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 27 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 27 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 26 is R 27 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 26 is R 27 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 26 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 26 is R 27 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 26 is R 27 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 26 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 26 is R 27 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 26 is R 27 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 26 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 26 is R 27 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 26 is R 27 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 26 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 26 is R 27 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 26 is R 27 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 26 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 26 is R 27 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 26 is R 27 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 26 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 27 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 28 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NH H 2 ,
  • R 29 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 29 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 29 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 29 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 29 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 28 is R 29 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 28 is R 29 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 28 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 28 is R 29 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 28 is R 29 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 28 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 28 is R 29 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 28 is R 29 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 28 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 28 is R 29 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 28 is R 29 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 28 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R is R -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 28 is R 29 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 28 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 28 is R 29 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 28 is R 29 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 28 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 29 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 30 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 30 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 30 - substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 30 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 30 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 29 is R 30 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 29 is R 30 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 29 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 29 is R 30 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 29 is R 30 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 29 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 29 is R 30 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 29 is R 30 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl.
  • R 29 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 29 is R 30 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 29 is R 30 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 29 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 29 is R 30 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 29 is R 30 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 29 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 29 is R 30 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 29 is R 30 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 29 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 30 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH,
  • unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -Ce alkyl, or C 1 -C4 alkyl
  • unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • unsubstituted aryl e.
  • R 31 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -N0 2 , -SH, -S0 3 H, -S0 4 H, -S0 2 NH 2 , -NHNH 2 , -ONH 2 , -NHC(0)NHNH 2 ,
  • R 32 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 32 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 32 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 32 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 32 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 31 is R 32 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 31 is R 32 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 31 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 31 is R 32 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 31 is R 32 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 31 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 31 is R 32 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 31 is R 32 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 31 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 31 is R 32 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 31 is R 32 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 31 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 31 is R 32 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 31 is R 32 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 31 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 31 is R 32 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 31 is R 32 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 31 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 32 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 33 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 33 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 33 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 33 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 33 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R is R -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 32 is R 33 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 32 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 32 is R 33 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 32 is R 33 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 32 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 32 is R 33 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 32 is R 33 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 32 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 32 is R 33 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 32 is R 33 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 32 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 32 is R 33 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 32 is R 33 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 32 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 32 is R 33 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 32 is R 33 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 32 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 33 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 34 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NH H2, -ONH2, -NHC(0)NHNH 2 ,
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 35 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 35 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 34 is R 35 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 34 is R 35 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 34 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 34 is R 35 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 34 is R 35 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 34 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 34 is R 35 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 34 is R 35 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 34 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 34 is R 35 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 34 is R 35 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 34 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 34 is R 35 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 34 is R 35 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 34 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 34 is R 35 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 34 is R 35 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 34 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 35 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH,
  • R 36 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 36 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 36 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 36 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 36 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 35 is R 36 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 35 is R 36 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 35 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 35 is R 36 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 35 is R 36 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 35 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 35 is R 36 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 35 is R 36 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 35 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 35 is R 36 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 35 is R 36 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 35 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 35 is R 36 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 35 is R 36 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 35 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 35 is R 36 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 35 is R 36 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 35 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 36 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 37 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NH H 2 ,
  • R 38 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 38 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 38 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • R 37 is R 38 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 37 is R 38 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 37 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 37 is R 38 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 37 is R 38 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 37 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 37 is R 38 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 37 is R 38 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 37 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 37 is R 38 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 37 is R 38 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 37 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 37 is R 38 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 37 is R 38 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 37 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 37 is R 38 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 37 is R 38 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 37 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 38 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 39 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 39 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 39 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 39 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 39 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 38 is R 39 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 38 is R 39 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 38 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 38 is R 39 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 38 is R 39 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 38 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 38 is R 39 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 38 is R 39 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 38 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 38 is R 39 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 38 is R 39 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 38 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 38 is R 39 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 38 is R 39 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 38 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 38 is R 39 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 38 is R 39 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 38 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 39 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -SO3H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 40 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -N0 2 , -SH, -S0 3 H, -S0 4 H, -S0 2 NH 2 , -NHNH 2 , -ONH 2 , -NHC(0)NHNH 2 ,
  • R 41 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 41 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 41 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 41 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 41 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 40 is R 41 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 40 is R 41 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 40 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 40 is R 41 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 40 is R 41 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 40 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 40 is R 41 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 40 is R 41 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 40 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R is R -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 40 is R 41 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 40 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 40 is R 41 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 40 is R 41 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 40 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 40 is R 41 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 40 is R 41 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 40 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 41 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 42 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 42 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 42 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 42 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 42 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R is R -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 41 is R 42 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 41 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 41 is R 42 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 41 is R 42 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 41 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 41 is R 42 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 41 is R 42 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 41 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 41 is R 42 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 41 is R 42 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 41 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 41 is R 42 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 41 is R 42 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 41 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 41 is R 42 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 41 is R 42 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 41 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 42 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 43 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NH H2, -ONH2, -NHC(0)NHNH 2 ,
  • R 44 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 44 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 44 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 44 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 44 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 43 is R 44 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 43 is R 44 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 43 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R is R -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 43 is R 44 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 43 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 43 is R 44 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 43 is R 44 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 43 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 43 is R 44 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 43 is R 44 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 43 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 43 is R 44 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 43 is R 44 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 43 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 43 is R 44 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 43 is R 44 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 43 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 44 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -SO3H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 , -NHC(0)NH 2 , -NHS0 2 H, -NHC(0)H, -NHC(0)OH, -NHOH, -OCCI3, -OCF3, -OCBr 3 , -OCI 3 ,-OCHCl 2 , -OCHBr 2 , -OCHI 2 , -OCHF 2 , R 45 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 45 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 45 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 44 is R 45 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 44 is R 45 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 44 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 44 is R 45 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 44 is R 45 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 44 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 44 is R 45 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 44 is R 45 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 44 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 44 is R 45 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 44 is R 45 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 44 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 44 is R 45 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 44 is R 45 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 44 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 44 is R 45 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 44 is R 45 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 44 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 45 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 59 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NH H 2 ,
  • R 60 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 60 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 60 - substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl
  • R 59 is R 60 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 59 is R 60 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 59 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 59 is R 60 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 59 is R 60 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 59 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 59 is R 60 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 59 is R 60 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 59 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 59 is R 60 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 59 is R 60 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 59 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 59 is R 60 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 59 is R 60 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 59 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R is R -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 59 is R 60 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 59 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 60 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 61 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 61 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 61 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalky
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 61 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 61 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 60 is R 61 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 60 is R 61 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 60 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 60 is R 61 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 60 is R 61 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 60 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R is R -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 60 is R 61 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 60 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 60 is R 61 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 60 is R 61 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 60 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 60 is R 61 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 60 is R 61 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 60 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 60 is R 61 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 60 is R 61 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 60 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 61 is independently oxo, halogen, -CCI3, -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -SO3H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 65 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -N0 2 , -SH, -S0 3 H, -S0 4 H, -S0 2 NH 2 , -NHNH 2 , -ONH 2 , -NHC(0)NHNH 2 ,
  • R 66 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 66 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 66 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 66 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 66 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R 65 is R 66 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 65 is R 66 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 65 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 65 is R 66 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 65 is R 66 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 65 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 65 is R 66 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 65 is R 66 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 65 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl).
  • R is R -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 65 is R 66 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 65 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 65 is R 66 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 65 is R 66 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 65 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 65 is R 66 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 65 is R 66 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 65 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 66 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH 2 , -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 67 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 67 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 67 - substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycl
  • heterocycloalkyl 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 67 - substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 67 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl.
  • R is R -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 66 is R 67 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl).
  • R 66 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 66 is R 67 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 66 is R 67 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 66 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 66 is R 67 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 66 is R 67 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 66 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 66 is R 67 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 66 is R 67 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 66 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 66 is R 67 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 66 is R 67 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 66 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 66 is R 67 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 66 is R 67 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 66 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 67 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 59D , R 61 , R 65A , R 65B , R 65C , R 65D and R 67 are independently hydrogen, oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -S0 4 H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NH H 2 , -NHC(0)NH 2 , -NHSO2H, -NHC(0)H, -NHC(0)OH, -NHOH, -OCCl 3 , -OCF 3 , -OCBr 3 , -OCI 3 ,-OCHCl 2 , -OCHBr 2 , -OCHI2, -OCHF2, unsubstituted alkyl (e.g., C 1 -C
  • X 11 , X 21 , X 31 , X 41 , X 51 , X 61 , X 71 , X 81 , X 91 , X 101 , X 111 and X 171 are independently -CI, -Br, -I or -F.
  • X 1 1 is -CI.
  • X 1 1 is -F.
  • X 1 1 is -Br.
  • X 1 1 is -I. In embodiments, X 2 1 is -CI. In embodiments, X 2 1 is -F. In embodiments, X 2 1 is -Br. In embodiments, X 2 1 is -I. In embodiments, X' 1 is CI. In embodiments, X 1 1 is -F. In embodiments, X 1 1 is -Br. In embodiments, X 3.1 is I. In
  • X 4.1 is -CI. In embodiments, X 4.1 is -F. In embodiments, X 4.1 is Br. In embodiments, X 4.1 is -I. In embodiments, X 5 1 is -CI. In embodiments, X 5 1 is F. In
  • X 5 1 is -Br.
  • X s 1 is -I.
  • X 6 1 is CI.
  • X 6 1 is -F.
  • X 6 1 is -Br.
  • X 6 1 is -I.
  • X 7 1 is -CI. In embodiments, X 7 1 is -F. In embodiments, X 7 1 is Br. In embodiments, X 7 1 is -I. In embodiments, X s 1 is -CI. In embodiments, X 8 1 is F. In
  • X s 1 is -Br. In embodiments, X s 1 is -I. In embodiments, X 9. 1 is CI. In embodiments, X 9. 1 is -F. In embodiments, X 9. 1 is -Br. In embodiments, X 9. 1 is -I. In
  • X 10 1 is -CI. In embodiments, X 10 1 is -F. In embodiments, X 10 1 is -Br. In embodiments, X 10 1 is -I. In embodiments, X 1 1 1 is -F. In embodiments, X 1 1 1 is -Br. In embodiments, X 1 1 1 is -I. In embodiments, X 17 1 is -F. In embodiments, X 17 1 is -Br. In embodiments, X 17 1 is -I.
  • X 1 1 is -CI, and X 1 is N.
  • X 1 1 is -F, and X 1 is N.
  • X 1 1 is -Br, and X 1 is N.
  • X 1 1 is -I, and X 1 is N.
  • X 2 1 is -CI, and X 1 is N.
  • X 2 1 is -F, and X 1 is N.
  • X 2 1 is -Br, and X 1 is N.
  • X 2 1 is -I, and X 1 is N.
  • X 3.1 is -CI, and X 1 is N.
  • X 3.1 is -F, and X 1 is N. In embodiments, X 3.1 is -Br, and X 1 is N. In embodiments, X 3.1 is -I, and X 1 is N. In embodiments, X 4.1 is -CI, and X 1 is N. In
  • X 4.1 is -F, and X 1 is N. In embodiments, X 4.1 is -Br, and X 1 is N. In embodiments, X 4.1 is -Br, and X 1 is N. In embodiments, X 4.1 is -Br, and X 1 is N. In
  • X 4.1 is -I, and X 1 is N.
  • X 5 1 is -CI, and X 1 is N.
  • X 5 1 is -F, and X 1 is N. In embodiments, X 5 1 is -Br, and X 1 is N. In
  • X s 1 is -I, and X 1 is N.
  • X 6 1 is -CI, and X 1 is N.
  • X 6 1 is -F, and X 1 is N. In embodiments, X 6 1 is -Br, and X 1 is N. In
  • X 6 1 is -I, and X 1 is N.
  • X 7 1 is -CI, and X 1 is N.
  • X 7 1 is -F, and X 1 is N. In embodiments, X 7 1 is -Br, and X 1 is N. In
  • X 7 1 is -I, and X 1 is N.
  • X 8 1 is -CI, and X 1 is N.
  • X 8 1 is F, and X 1 is N.
  • X 8 1 is -Br, and X 1 is N.
  • X 8 1 is -I, and X 1 is N.
  • X 9. 1 is -CI, and X 1 is N.
  • X 9. 1 is -F, and X 1 is N. In embodiments, X 9. 1 is -Br, and X 1 is N. In embodiments, X 9. 1 is -Br, and X 1 is N. In embodiments, X 9. 1 is -Br, and X 1 is N. In
  • X 9. 1 is -I, and X 1 is N.
  • X 10 1 is -CI, and X 1 is N.
  • X 10 1 is -F, and X 1 is N. In embodiments, X 10 1 is -Br, and X 1 is N. In
  • X 10 1 is -I, and X 1 is N. In embodiments, X 10 1 is -CI, and X 1 is N. In embodiments, X 10 1 is -CI, and X 1 is N. In embodiments, X 10 1 is -CI, and X 1 is N. In
  • X 10 1 is -F, and X 1 is N. In embodiments, X 10 1 is -Br, and X 1 is N. In
  • X 1 1 1 is -I, and X 1 is N.
  • X 11 1 is -F, and X 1 is N.
  • X 1 1 1 is -Br, and X 1 is N.
  • X 11 1 is -I, and X 1 is N.
  • X 17 1 is -I, and X 1 is N. In embodiments, X 17 1 is -F, and X 1 is N. In embodiments, X 17 1 is -I, and X 1 is N. In embodiments, X 17 1 is -F, and X 1 is N. In
  • X 17 1 is -Br, and X 1 is N. In embodiments, X 17 1 is -I, and X 1 is N.
  • X 1 1 is -CI, and X 2 is N.
  • X 1 1 is -F, and X 2 is N.
  • X 1 1 is -Br, and X 2 is N.
  • X 1 1 is -I, and X 2 is N.
  • X 2 1 is -CI, and X 2 is N.
  • X 2 1 is -F, and X 2 is N.
  • X 2 1 is -Br, and X 2 is N.
  • X 2 1 is -I, and X 2 is N.
  • X 3.1 is -CI, and X 2 is N.
  • X 3.1 is -F, and X 2 is N. In embodiments, X 3.1 is -Br, and X 2 is N. In embodiments, X 3.1 is -I, and X 2 is N. In embodiments, X 4.1 is -CI, and X 2 is N. In
  • X 4.1 is -F, and X 2 is N. In embodiments, X 4.1 is -Br, and X 2 is N. In embodiments, X 4.1 is -Br, and X 2 is N. In embodiments, X 4.1 is -Br, and X 2 is N. In
  • X 4.1 is -I, and X 2 is N.
  • X 5 1 is -CI, and X 2 is N.
  • X 5 1 is -F, and X 2 is N. In embodiments, X 5 1 is -Br, and X 2 is N. In embodiments, X 5 1 is -Br, and X 2 is N. In
  • X 5 1 is -I
  • X 2 is N
  • X 6 1 is -CI
  • X 2 is N.
  • X 6 1 is -F, and X 2 is N. In embodiments, X 6 1 is -Br, and X 2 is N. In
  • X 6 1 is -I
  • X 2 is N
  • X 7 1 is -CI
  • X 2 is N.
  • X 7 1 is -F, and X 2 is N. In embodiments, X 7 1 is -Br, and X 2 is N. In embodiments, X 7 1 is -Br, and X 2 is N. In
  • X 7 1 is -I
  • X 2 is N
  • X 8 1 is -CI
  • X 2 is N.
  • X 8 1 is -F, and X 2 is N. In embodiments, X 8 1 is -Br, and X 2 is N. In embodiments, X 8 1 is -Br, and X 2 is N. In
  • X 8 1 is -I, and X 2 is N.
  • X 9. 1 is -CI, and X 2 is N.
  • X 9. 1 is -F, and X 2 is N. In embodiments, X 9. 1 is -Br, and X 2 is N. In embodiments, X 9. 1 is -Br, and X 2 is N. In embodiments, X 9. 1 is -Br, and X 2 is N. In
  • X 9. 1 is -I, and X 2 is N.
  • X 10 1 is -CI, and X 2 is N.
  • X 10 1 is -F, and X 2 is N. In embodiments, X 10 1 is -Br, and X 2 is N. In embodiments, X 101 is -I, and X 2 is N. In embodiments, X 111 is -CI, and X 2 is N. In
  • X 111 is -F, and X 2 is N. In embodiments, X 111 is -Br, and X 2 is N. In
  • X 111 is -I, and X 2 is N.
  • X 171 is -CI, andX 2 is N.
  • X 171 is -F, and X 2 is N. In embodiments, X 171 is -Br, and X 2 is N. In embodiments, X 171 is -Br, and X 2 is N. In
  • X 171 is -I
  • X 2 is N.
  • X 11 is -CI, and X 3 is N.
  • X 11 is -F, and X 3 is N.
  • X 11 is -Br, and X 3 is N.
  • X 11 is -I, and X 3 is N.
  • X 21 is -CI, and X 3 is N.
  • X 21 is -F, and X 3 is N.
  • X 21 is -Br, and X 3 is N.
  • X 21 is -I, and X 3 is N.
  • X 31 is -CI, and X 3 is N.
  • X 31 is -F, and X 3 is N. In embodiments, X 31 is -Br, and X 3 is N. In embodiments, X 31 is -I, and X 3 is N. In embodiments, X 41 is -CI, and X 3 is N. In
  • X 41 is -F, and X 3 is N. In embodiments, X 41 is -Br, and X 3 is N. In
  • X 41 is -I, and X 3 is N.
  • X 1 is -CI, and X 3 is N.
  • X 51 is -F, and X 3 is N.
  • X 1 is -Br, and X 3 is N.
  • X 51 is -I, and X 3 is N.
  • X 61 is -CI, and X 3 is N.
  • X 61 is -F, and X 3 is N. In embodiments, X 61 is -Br, and X 3 is N. In
  • X 61 is -I, and X 3 is N.
  • X 71 is -CI, and X 3 is N.
  • X 71 is -F, and X 3 is N. In embodiments, X 71 is -Br, and X 3 is N. In embodiments, X 71 is -Br, and X 3 is N. In
  • X 71 is -I, and X 3 is N.
  • X s 1 is -CI, and X 3 is N.
  • X 81 is -F, and X 3 is N.
  • X s 1 is -Br, and X 3 is N.
  • X 81 is -I, and X 3 is N.
  • X 91 is -CI, and X 3 is N.
  • X 91 is -F, and X 3 is N. In embodiments, X 91 is -Br, and X 3 is N. In embodiments, X 91 is -Br, and X 3 is N. In
  • X 91 is -I, and X 3 is N.
  • X 101 is -CI, and X 3 is N.
  • X 101 is -F, and X 3 is N. In embodiments, X 101 is -Br, and X 3 is N. In
  • X 101 is -I, and X 3 is N.
  • X 111 is -CI, and X 3 is N.
  • X 111 is -F, and X 3 is N. In embodiments, X 111 is -Br, and X 3 is N. In
  • X 111 is -I, and X 3 is N.
  • X 171 is -F, and X 3 is N.
  • X 171 is -Br, and X 3 is N. In embodiments, X 171 is -I, and X 3 is N.
  • nl, n2, n3, n4, n5, n6, n8, n9, nlO, nl 1 and nl7 are independently an integer from 0 to 4.
  • nl is 0.
  • nl is 1.
  • nl is 2.
  • nl is 3.
  • nl is 4.
  • n2 is
  • n2 is 1. In embodiments, n2 is 2. In embodiments, n2 is 3. In embodiments, n2 is 4. In embodiments, n3 is 0. In embodiments, n3 is 1. In embodiments, n3 is 2. In embodiments, n3 is 3. In embodiments, n3 is 4. In embodiments, n4 is 0. In embodiments, n4 is
  • n4 is 2. In embodiments, n4 is 3. In embodiments, n4 is 4. In
  • n5 is 0. In embodiments, n5 is 1. In embodiments, n5 is 2. In embodiments, n5 is 3. In embodiments, n5 is 4. In embodiments, n6 is 0. In embodiments, n6 is 1. In embodiments,
  • n6 is 2. In embodiments, n6 is 3. In embodiments, n6 is 4. In embodiments, n8 is
  • n8 is 1. In embodiments, n8 is 2. In embodiments, n8 is 3. In
  • n8 is 4. In embodiments, n9 is 0. In embodiments, n9 is 1. In embodiments, n9 is
  • n9 is 3. In embodiments, n9 is 4. In embodiments, nlO is 0. In
  • nlO is 1. In embodiments, nlO is 2. In embodiments, nlO is 3. In embodiments, nlO is 4. In embodiments, nl 1 is 0. In embodiments, nl 1 is 1. In embodiments, nl 1 is 2. In embodiments, nl 1 is 3. In embodiments, nl 1 is 4. In embodiments, nl7 is 0. In embodiments, nl7 is 1. In embodiments, nl7 is 2. In embodiments, nl7 is 3. In embodiments, nl7 is 4.
  • the symbols ml , m2, m3, m4, m5m m6, m8, m9, mlO, ml 1 , ml7, vl , v2, v3, v4, v5, v6, v8, v9, vlO, vl 1 , and vl 7 are independently 1 or 2.
  • ml is 1.
  • ml is 2.
  • m2 is 1.
  • m2 is 2.
  • m3 is 1.
  • m3 is 2.
  • m4 is 1.
  • m4 is 2.
  • m5 is 1.
  • m5 is 2.
  • m6 is 1. In embodiments, m6 is 2. In embodiments, m8 is 1. In embodiments, m8 is 2. In embodiments, m9 is 1. In embodiments, m9 is 2. In embodiments, ml 0 is 1. In embodiments, ml 0 is 2. In embodiments, ml 1 is 1. In embodiments, ml 1 is 2. In embodiments, ml 7 is 1. In embodiments, ml7 is 2. In embodiments, vl is 1. In embodiments, vl is 2. In embodiments, v2 is 1. In embodiments, v2 is 2. In embodiments, v3 is 1. In embodiments, v3 is 2. In embodiments, v4 is 1. In embodiments, v4 is 2. In embodiments, v5 is 1. In embodiments, v5 is 2. In embodiments, v6 is
  • v6 is 2.
  • v8 is 1.
  • v8 is 2.
  • v9 is 1. In embodiments, v9 is 2. In embodiments, vlO is 1. In embodiments, vlO is 2. In embodiments, vl 1 is 1. In embodiments, vl 1 is 2. In embodiments, vl7 is 1. In embodiments, vl7 is 2. [0432] In embodiments, the symbol zl is an integer from 0 to 5. In embodiments, zl is 0. In embodiments, zl is 1. In embodiments, zl is 2. In embodiments, zl is 3. In embodiments, zl is 4. In embodiments, zl is 5.
  • the symbol z2 is an integer from 0 to 8. In embodiments, z2 is 0. In embodiments, z2 is 1. In embodiments, z2 is 2. In embodiments, z2 is 3. In embodiments, z2 is 4. In embodiments, z2 is 5. In embodiments, z2 is 6. In embodiments, z2 is 7. In embodiments, z2 is 8.
  • z3 is an integer from 0 to 12. In embodiments, z3 is an integer from 0 to 2. In embodiments, z3 is 0. In embodiments, z3 is 1. In embodiments, z3 is 2. In embodiments, z3 is 3. In embodiments, z3 is 4. In embodiments, z3 is 5. In embodiments, z3 is 6. In
  • z3 is 7. In embodiments, z3 is 8. In embodiments, z3 is 9. In embodiments, z3 is 10. In embodiments, z3 is 1 1. In embodiments, z3 is 12.
  • z2 and z3 are independently an integer from 0 to 2.
  • X 5 is CR 12 R 13 or NR 12 .
  • X 6 is CR 14 , CR 14 R 15 , N or
  • NR 16 is a single bond or double bond, wherein if is a single bond, then X 6 is CR 14 R 15 or NR 16 , and if is a double bond, then X 6 is N or CR 14 .
  • R 12 is hydrogen, halogen, -CX 12 1 3 , - CHX 12 1 2, -CH2X 12 1 , -CN, -SOêti 2 R 12A , -SOvi 2 NR 12B R 12C , -NHNR 12B R 12C , -ONR 12B R 12C , -NHC(0)NHNR 12B R 12C , -NHC(0)NR 12B R 12C , -N(0) m i2, NR 12B R 12C , C(0)R 12D , C(0)OR 12D , C(0)NR 12B R 12C , OR 12A , -NR 12B S0 2 R 12A , -NR 12B C(0)R 12D , -NR 12B C(0)OR 12
  • R 13 is hydrogen, halogen, -CX 13 1 3 , -CHX 13 1 2 , -CH 2 X 13 1 , -CN, -SO existencei 3 R 13A , -SO v i 3 NR 13B R 13C , -NHNR 13B R 13C , -ONR 13B R 13C , -NHC(0)NHNR 13B R 13C , -NHC(0)NR 13B R 13C , -N(0) m i 3 , NR 13B R 13C , C(0)R 13D , C(0)OR 13D , C(0)NR 13B R 13C , OR 13A , -NR 13B S0 2 R 13A , - NR 13B C(0)R 13D , -NR 13B C(0)OR 13D , NR 13B OR 13D , -OCX M 3 , OCHX 13 - OCH 2 X 13 1 , substituted or unsubstituted alkyl, substituted or un
  • R 14 is hydrogen, halogen, -CX 14.1 3 , -CHX 14.1 2, -CH2X 14.1 , -CN, -SOfinityHR 14A , -SOVI 4 NR 14B R 14C , -NHNR 14B R 14C , -ONR 14B R 14C , -NHC(0)NHNR 14B R 14C , -NHC(0)NR 14B R 14C , -N(0) m i4, -NR 14B R 14C , -C(0)R 14D , -C(0)OR 14D , C(0)NR 14B R 14C , OR 14A , -NR 14B S0 2 R 14A , -NR 14B C(0)R 14D , -NR 14B C(0)OR 14D , NR 14B OR 14D , OCX 14 S, -OCHX 14.1 2 , -OCH 2 X 14.1 , substituted or unsubstituted alkyl, substituted or
  • R 15 is hydrogen, halogen, -CX 15 1 3 , -CHX 15 1 2 , -CH 2 X 15 1 , -CN, -SOsolutioni 5 R 15A , -SO v i 5 NR 15B R 15C , -NHNR 15B R 15C , -ONR 15B R 15C , -NHC(0)NHNR 15B R 15C , -NHC(0)NR 15B R 15C , -N(0)mis, NR 15B R 15C , C(0)R 15D , C(0)OR 15D , C(0)NR 15B R 15C , OR 15A , -NR 15B S0 2 R 15A , - NR 15B C(0)R 15D , -NR 15B C(0)OR 15D , NR 15B OR 15D , -OCX 15 - ⁇ , OCHX 15 - OCH 2 X 15 1 , substituted or unsubstituted alkyl, substituted or unsubstit
  • R 16 is hydrogen, halogen, -CX 16 1 3 , -CHX 16 1 2 , -CH 2 X 16 1 , -CN, -SOitatii 6 R 16A , -SO v i 6 NR 16B R 16C , -NHNR 16B R 16C , -ONR 16B R 16C , -NHC(0)NHNR 16B R 16C , -NHC(0)NR 16B R 16C , -N(0) m i6, -NR 16B R 16C , -C(0)R 16D , -C(0)OR 16D , C(0)NR 16B R 16C , OR 16A , -NR 16B S0 2 R 16A , -NR 16B C(0)R 16D , -NR 16B C(0)OR 16D , NR 16B OR 16D , -OCX 16 1 3 , -OCHX 16 1 2 , -OCH 2 X 16 1 , substituted or unsubstitute
  • R 16B , R 16C and R 16D are independently hydrogen, halogen, -CF 3 , -CCl 3 , -CBr 3 , -CI 3 ,-COOH, - CONH 2 , substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.
  • R 12B and R 12C , R 13B and R 13C , R 14B and R 14C , R 15B and R 15C and R 16B and R 16C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.
  • X 12 1 , X 13.1 , X 14.1 , X 15 1 and X 16 1 are independently -CI, -Br, -I or -F.
  • the symbols nl2, nl3, nl4, nl5, and nl 6 are independently an integer from 0 to 4.
  • the symbols ml2, ml 3, ml4, ml 5, ml6, vl2, vl3, vl4, vl5, and vl6 are independently 1 or 2.
  • the symbol z5 is an integer from 0 to 3.
  • zl , z2, z3, X 1 , X 2 , X 3 , X 4 , X 7 , L 7 , R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as described herein, including embodiments.
  • X 5 is CR 12 R 13 or NR 12 . ⁇ embodiments, X 5 is CR 12 R 13 . In embodiments, X 5 is NR 12 .
  • X 6 is CR 14 , CR 14 R 15 , N or NR 16 . In embodiments, X 6 is CR 14 R 15 . In embodiments, X 6 is CR 14 . In embodiments, X 6 is N. In embodiments, X 6 is NR 16 .
  • nl 2 is 0. In embodiments, nl 2 is 1. In embodiments, nl 2 is 2. In embodiments, nl2 is 3. In embodiments, nl2 is 4. In embodiments, nl 3 is 0. In embodiments, nl3 is 1. In embodiments, nl3 is 2. In embodiments, nl3 is 3. In embodiments, nl3 is 4. In embodiments, nl4 is 0. In embodiments, nl4 is 1. In embodiments, nl4 is 2. In embodiments, nl4 is 3. In embodiments, nl4 is 4. In embodiments, nl5 is 0. In embodiments, nl5 is 1. In embodiments, nl5 is 2.
  • nl 5 is 3. In embodiments, nl 5 is 4. In embodiments, nl6 is 0. In embodiments, nl6 is 1. In embodiments, nl6 is 2. In embodiments, nl6 is 3. In embodiments, nl6 is 4.
  • ml2 is 1. In embodiments, ml2 is 2. In embodiments, ml 3 is 1. In embodiments, ml 3 is 2. In embodiments, ml4 is 1. In embodiments, ml4 is 2. In embodiments,
  • ml 5 is 1. In embodiments, ml 5 is 2. In embodiments, ml 6 is 1. In
  • ml 6 is 2. In embodiments, vl2 is 1. In embodiments, vl2 is 2. In embodiments, vl3 is 1. In embodiments, vl3 is 2. In embodiments, vl4 is 1. In embodiments, vl4 is 2. In embodiments, vl5 is 1. In embodiments, vl5 is 2. In embodiments, vl6 is 1. In embodiments, vl6 is 2. [0442] In embodiments, z5 is 0. In embodiments, z5 is 1. In embodiments, z5 is 2. In embodiments, z5 is 3.
  • z5 is 0 or 1.
  • the symbol is a sing le bond and X 6 is CR 14 R 15 or NR 16 .
  • the symbol ⁇ is a double bond and X 6 is N or CR 14 .
  • R 12 is hydrogen, halogen, -CX 12 1 3 , -CHX 12 1 2 , -CH 2 X 12 1 , -CN, SOSONi 2 R 12A , SOvi 2 NR 12B R 12C , -NHNR 12B R 12C , -ONR 12B R 12C , -NHC(0)NHNR 12B R 12C , -NHC(0)NR 12B R 12C , -N(0)mi2, NR 12B R 12C , C(0)R 12D , C(0)OR 12D , C(0)NR 12B R 12C , OR 12A ,
  • R 46 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -Ce alkyl, or C 1 -C 4 alkyl
  • R 46 -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 46 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl
  • R 46 -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -Ce alkyl, or C 1 -C 4 alkyl
  • R 12 is R 46 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 12 is R 46 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 12 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 12 is R 46 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 12 is R 46 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 12 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 12 is R 46 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 12 is R 46 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 12 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 12 is R 46 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 12 is R 46 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 12 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 12 is R 46 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 12 is R 46 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 12 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 12 is R 46 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 12 is R 46 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 12 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 12 is hydrogen or -CHX 12 J 2 .
  • z5 is 0 or 1 and R 12 is hydrogen or -CHX 12 1 2 .
  • R 13 is hydrogen, halogen, -CX 13.1 3 , -CHX 13.1 2 , -CH 2 X 13.1 , -CN, -
  • R 49 -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 49 -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 49 -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 49 -substituted or unsubstituted heteroaryl e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membere
  • R 13 is R 49 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 13 is R 49 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 13 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 13 is R 49 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 13 is R 49 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 13 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 13 is R 49 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 13 is R 49 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 13 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 13 is R 49 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 13 is R 49 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 13 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 13 is R 49 -substituted or unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 13 is R 49 -substituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl). In embodiments, R 13 is an unsubstituted aryl (e.g., C 6 -C10 aryl, C10 aryl, or phenyl).
  • R 13 is R 49 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 13 is R 49 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 13 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 14 is hydrogen, halogen, -CX 14.1 , -CHX 14.1 2 , -CH 2 X 14.1 , -CN, SOorderHR 14A , SOVHNR 14B R 14C , -NHNR 14B R 14C , -ONR 14B R 14C , -NHC(0)NHNR 14B R 14C , -NHC(0)NR 14B R 14C , -N(0)mi4, NR 14B R 14C , C(0)R 14D , C(0)OR 14D , C(0)NR 14B R 14C , OR 14A ,
  • R 14A -NR 14B C(0)R 14D , -NR 14B C(0)OR 14D , NR 14B OR 14D , -OCX 14 - 1 , OCHX 14 -OCH 2 X 14.1 , R 52 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 52 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 52 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl), R
  • R 14 is R 52 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 14 is R 52 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 14 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 14 is R 52 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 14 is R 52 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 14 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 14 is R 52 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl).
  • R 14 is R 52 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 14 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 14 is R 52 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 14 is R 52 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 14 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 14 is R 52 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 14 is R 52 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 14 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 14 is R 52 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 14 is R 52 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 14 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 15 is hydrogen, halogen, -CX 15 1 , -CHX 15 1 2 , -CH 2 X 15 1 , -CN, SOpolei 5 R 15A , SOvi 5 NR 15B R 15C , -NHNR 15B R 15C , -ONR 15B R 15C , -NHC(0)NHNR 15B R 15C , -NHC(0)NR 15B R 15C , N(0)mi5, NR 15B R 15C , C(0)R 15D , C(0)OR 15D , C(0)NR 15B R 15C , OR 15A , -NR 15B S0 2 R 15A , -NR 15B C(0)R 15D , -NR 15B C(0)OR 15D , NR 15B OR 15D , OCX 15 - OCHX 15 1 2 , -OCH 2 X 15 1 , R 55 -substituted or unsubstituted alkyl (e.g., OCX 15
  • R 15 is R 55 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 15 is R 55 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 15 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 15 is R 55 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 15 is R 55 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 15 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 15 is R 55 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C5 cycloalkyl, or C5-C6 cycloalkyl).
  • R 15 is R 55 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 15 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 15 is R 55 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 15 is R 55 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 15 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 15 is R 55 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 15 is R 55 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 15 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 15 is R 55 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 15 is R 55 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 15 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 16 is hydrogen, halogen, -CX 16 1 , -CHX 16 1 2 , -CH 2 X 16 1 , -CN, - SOTONi 6 R 16A , -SOvieNR 16B R 16C , -NHNR 16B R 16C , -ONR 16B R 16C , -NHC(0)NHNR 16B R 16C , -NHC(0)NR 16B R 16C , -N(0)mi6, -NR 16B R 16C , -C(0)R 16D , -C(0)OR 16D , -C(0)NR 16B R 16C , - OR 16A , -NR 16B S0 2 R 16A , -NR 16B C(0)R 16D , -NR 16B C(0)OR 16D , NR 16B OR 16D , -OCX 16 - 1 , OCHX 16 1 2 , -OCH 2 X 16 1 , R 62 -sub
  • R 16 is R 62 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 16 is R 62 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl). In embodiments, R 16 is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).
  • R 16 is R 62 -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 16 is R 62 -substituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl). In embodiments, R 16 is an unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl).
  • R 16 is R 62 -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl). In embodiments, R 16 is R 62 -substituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 16 is an unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl).
  • R 16 is R 62 -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 16 is R 62 -substituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 16 is an unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered
  • R 16 is R 62 -substituted or unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 16 is R 62 -substituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl). In embodiments, R 16 is an unsubstituted aryl (e.g., C5-C10 aryl, C10 aryl, or phenyl).
  • R 16 is R 62 -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 16 is R 62 -substituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl). In embodiments, R 16 is an unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • R 12B and R 12C , R 13B and R 13C , R 14B and R 14C , R 15B and R 15C and R 16B and R 16C substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl or substituted or unsubstituted heteroaryl.
  • R 12A is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 46A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 46A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 46A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C5 cycloalkyl), R 46A -substituted or unsubstituted or unsubstituted
  • R 13A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 49A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 49A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 49A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 49A -substituted or unsubstituted or unsubstit
  • R 14A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 52A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 52A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 52A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 52A -substituted or unsubstituted or unsubstit
  • R 15A is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, -
  • R 55A -substituted or unsubstituted alkyl e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl
  • R 55A -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R 55A -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C5 cycloalkyl
  • R 55A -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 55A -substituted or unsubstituted heteroaryl e.g., 5 to
  • R 16A is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 62A -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 62A -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 62A -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl
  • R 12B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 46B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 46B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 46B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 46B -substituted or unsubstituted or unsubstit
  • R 12B and R 12C substituents bonded to the same nitrogen atom may optionally be joined to form a R 46B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 46B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 46B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 46B -substituted or unsubstituted heteroaryl e.g.,
  • R 13B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 49B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 49B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 49B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 49B -substituted or unsubstituted or unsubstit
  • R 13B and R 13C substituents bonded to the same nitrogen atom may optionally be joined to form a R 49B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 49B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 49B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 49B -substituted or unsubstituted heteroaryl e.g.,
  • R 14B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 52B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl), R 52B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 52B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 52B -substituted or unsubstituted or unsubstit
  • R 14B and R 14C substituents bonded to the same nitrogen atom may optionally be joined to form a R 52B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 52B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 52B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 52B -substituted or unsubstituted heteroaryl e.g.,
  • R 15B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 55B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C5 alkyl, or C 1 -C4 alkyl), R 55B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 55B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 55B -substituted or unsubstituted or unsubstit
  • R 15B and R 15C substituents bonded to the same nitrogen atom may optionally be joined to form a R 55B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 55B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 55B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 55B -substituted or unsubstituted heteroaryl e.g.,
  • R 16B is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 62B -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 62B -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 62B -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 62B -substituted or
  • R 16B and R 16C substituents bonded to the same nitrogen atom may optionally be joined to form a R 62B -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 62B -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 62B -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 62B -substituted or unsubstituted heteroaryl e
  • R 12C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 46C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 46C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 46C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 46C -substituted or unsubstituted or unsubstit
  • R 12B and R 12C substituents bonded to the same nitrogen atom may optionally be joined to form a R 46C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 46C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 46C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 46C -substituted or unsubstituted heteroaryl e.g.,
  • R 13C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 49C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 49C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 49C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 49C -substituted or unsubstituted or unsubstit
  • R 13B and R 13C substituents bonded to the same nitrogen atom may optionally be joined to form a R 49C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 49C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 49C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 49C -substituted or unsubstituted heteroaryl e.g.,
  • R 14C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 52C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 52C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 52C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 52C -substituted or unsubstituted or unsubstit
  • R 14B and R 14C substituents bonded to the same nitrogen atom may optionally be joined to form a R 52C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 52C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R -substituted or unsubstituted heteroaryl e.g., 5 to 10 member
  • R 15C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 55C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 55C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 55C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 55C -substituted or unsubstituted or unsubstit
  • R 15B and R 15C substituents bonded to the same nitrogen atom may optionally be joined to form a R 55C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 55C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 55C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 55C -substituted or unsubstituted heteroaryl e.g.,
  • R 16C is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 62C -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 62C -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 62C -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 62C -substituted or
  • R 16B and R 16C substituents bonded to the same nitrogen atom may optionally be joined to form a R 62C -substituted or unsubstituted heterocycloalkyl (e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl) or R 62C -substituted or unsubstituted heteroaryl (e.g., 5 to 10 membered heteroaryl, 5 to 9 membered heteroaryl, or 5 to 6 membered heteroaryl).
  • a R 62C -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 62C -substituted or unsubstituted heteroaryl e
  • R 12D is hydrogen, halogen, -CF 3 , -CCI3, -CBr 3 , -CI 3 ,-COOH, - CONH2, R 46D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 46D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 46D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 46D -substituted or unsubstituted or unsubstituted
  • R 13D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 49D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 49D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 49D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 49D -substituted or unsubstituted or unsubstit
  • R 14D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 52D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 52D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 52D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 52D -substituted or unsubstituted or unsubstit
  • R 15D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, -
  • R 55D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl),
  • R 55D -substituted or unsubstituted heteroalkyl e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl
  • R -substituted or unsubstituted cycloalkyl e.g., C 3 -C 8 cycloalkyl, C 3 -C6 cycloalkyl, or C5-C6 cycloalkyl
  • R 55D -substituted or unsubstituted heterocycloalkyl e.g., 3 to 8 membered heterocycloalkyl, 3 to 6 membered heterocycloalkyl, or 5 to 6 membered heterocycloalkyl
  • R 55D -substituted or unsubstituted aryl e.g., C 6 -C10 aryl, C10 aryl, or phenyl
  • R 16D is hydrogen, halogen, -CF 3 , -CC1 3 , -CBr 3 , -CI 3 ,-COOH, - CONH2, R 62D -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl), R 62D -substituted or unsubstituted heteroalkyl (e.g., 2 to 8 membered heteroalkyl, 2 to 6 membered heteroalkyl, or 2 to 4 membered heteroalkyl), R 62D -substituted or unsubstituted cycloalkyl (e.g., C 3 -C 8 cycloalkyl, C 3 -C 6 cycloalkyl, or C5-C6 cycloalkyl), R 62D -substituted or
  • R 46 is independently oxo, halogen, -CC1 3 , -CBr 3 , -CF 3 , -CI 3 ,-CN, -OH, -NH 2 , -COOH, -CONH2, -NO2, -SH, -S0 3 H, -SO4H, -SO2NH2, -NHNH2, -ONH2, -NHC(0)NHNH 2 ,
  • R 46 is R 47 -substituted or unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R 46 is R 47 -substituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl). In embodiments, R is an unsubstituted alkyl (e.g., C 1 -C 8 alkyl, C 1 -C 6 alkyl, or C 1 -C4 alkyl).

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne, entre autres, des composés de formule (I) et des procédés d'utilisation de ceux-ci pour la modulation de l'activité de CCR4.
PCT/US2018/026139 2017-04-04 2018-04-04 Composés hétérocycliques utilisés en tant que modulateurs du récepteur de chimiokine Ceased WO2018187509A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762481515P 2017-04-04 2017-04-04
US62/481,515 2017-04-04

Publications (1)

Publication Number Publication Date
WO2018187509A1 true WO2018187509A1 (fr) 2018-10-11

Family

ID=62067804

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/026139 Ceased WO2018187509A1 (fr) 2017-04-04 2018-04-04 Composés hétérocycliques utilisés en tant que modulateurs du récepteur de chimiokine

Country Status (1)

Country Link
WO (1) WO2018187509A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019090272A1 (fr) * 2017-11-06 2019-05-09 Flx Bio, Inc. Modulateurs du récepteur de chimiokine pour le traitement de cancers positifs au virus epstein-barr
WO2024228132A1 (fr) * 2023-05-02 2024-11-07 Aurigene Oncology Limited Composés hétérocyclyle bicycliques condensés utilisés en tant que modulateurs de ccr4

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120015932A1 (en) 2009-02-26 2012-01-19 Heather Hobbs Pyrazole Derivatives Used as CCR4 Receptor Antagonists
WO2013082490A1 (fr) 2011-12-01 2013-06-06 Chemocentryx, Inc. Anilines substituées en tant qu'antagonistes de ccr(4)
WO2013082429A1 (fr) * 2011-12-01 2013-06-06 Chemocentryx, Inc. Benzimidazoles et benzopyrazoles substitués en tant qu'antagonistes de ccr(4)
WO2018049271A1 (fr) * 2016-09-09 2018-03-15 Flx Bio, Inc. Modulateurs des récepteurs de la chimiokine et leurs utilisations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120015932A1 (en) 2009-02-26 2012-01-19 Heather Hobbs Pyrazole Derivatives Used as CCR4 Receptor Antagonists
WO2013082490A1 (fr) 2011-12-01 2013-06-06 Chemocentryx, Inc. Anilines substituées en tant qu'antagonistes de ccr(4)
WO2013082429A1 (fr) * 2011-12-01 2013-06-06 Chemocentryx, Inc. Benzimidazoles et benzopyrazoles substitués en tant qu'antagonistes de ccr(4)
WO2018049271A1 (fr) * 2016-09-09 2018-03-15 Flx Bio, Inc. Modulateurs des récepteurs de la chimiokine et leurs utilisations

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
BERGE ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19, XP002675560, DOI: doi:10.1002/jps.2600660104
CHIANG, M. ET AL., J. AM. CHEM. SOC., vol. 136, no. 9, 2014, pages 3370 - 73
COMERFORD, I.; MCCOLL, S., IMMUNOL CELL BIOL, vol. 89, 2011, pages 183 - 84
GADHE, CG, MOL BIOSYST, vol. 11, no. 2, February 2015 (2015-02-01), pages 618 - 34
GENNARO: "Remington: The Science and Practice of Pharmacy, 20th Edition,", 2003, LIPPINCOTT, WILLIAMS & WILKINS
HORUK, TRENDS PHARM. SCI., vol. 15, 1994, pages 159 - 165
LE, Y. ET AL., CELLULAR & MOLEC IMMUNO, vol. 1, no. 2, 2004, pages 95 - 104
LI, W. ET AL., PROGRESS IN POLYMER SCIENCE, vol. 38, 2013, pages 421 - 44
LIEBERMAN, PHARMACEUTICAL DOSAGE FORMS, vol. 1-3, 1992
LLOYD, THE ART, SCIENCE AND TECHNOLOGY OF PHARMACEUTICAL COMPOUNDING, 1999
MUNSEN ET AL., ANALYT. BIOCHEM., vol. 107, 1980, pages 220 - 239
NESS, T. ET AL., J IMMUNOL, vol. 177, 2006, pages 7531 - 39
PICKAR, DOSAGE CALCULATIONS, 1999
POWER ET AL., J. BIOL. CHEM., vol. 270, 1995, pages 19495 - 500
RAMIREZ-MONTAGUT ET AL., ONCOGENE, vol. 22, 2003, pages 3180 - 87
SAWAYA ET AL., NEW ENGL. J. MED., vol. 349, 2003, pages 1501 - 09
SOKOL, C.; LUSTER, A., COLD SPRING HARB PROSPECT BIOL, 2015
TEICHER, B A, MOL CANCER THER, vol. 5, October 2006 (2006-10-01), pages 2435

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019090272A1 (fr) * 2017-11-06 2019-05-09 Flx Bio, Inc. Modulateurs du récepteur de chimiokine pour le traitement de cancers positifs au virus epstein-barr
US11730736B2 (en) 2017-11-06 2023-08-22 Rapt Therapeutics, Inc. Anticancer agents
WO2024228132A1 (fr) * 2023-05-02 2024-11-07 Aurigene Oncology Limited Composés hétérocyclyle bicycliques condensés utilisés en tant que modulateurs de ccr4

Similar Documents

Publication Publication Date Title
JP7700196B2 (ja) Ａ２ａ／ａ２ｂ阻害剤としての縮合ピラジン誘導体
JP7034084B2 (ja) Ｔａｍ阻害剤としてのピロロトリアジン化合物
CA3215949A1 (fr) Composes d'oxazepine et leurs utilisations dans le traitement du cancer
JP7631317B2 (ja) Ａ２ａ／ａ２ｂ阻害剤としてのトリアゾロピリミジン
CA3214900A1 (fr) Polytherapies comprenant des inhibiteurs de mytl
IL311187A (en) Compressed ring compounds
JP2021176857A (ja) Ｒｓｋ阻害剤として有用なカルボキサミド誘導体
TWI623538B (zh) 三環化合物
MX2010010619A (es) Moduladores de quimioquina.
US20160115168A1 (en) Novel fused pyrimidine compound or salt thereof
CN114790209A (zh) 优化的联合用药及其治疗癌症和自身免疫疾病的用途
JP2021176819A (ja) キナゾリン化合物を有効成分とする医薬組成物
US20180072743A1 (en) Chemokine receptor modulators and uses thereof
EA015779B1 (ru) Соединения для ингибирования митоза
JP2024500378A (ja) 多環状ｉｒａｋ及びｆｌｔ３阻害化合物、並びにその使用
JP2022539208A (ja) チロシンキナーゼ非受容体１（ｔｎｋ１）阻害剤およびその使用
US20220041588A1 (en) Substituted imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine compounds as ret kinase inhibitors
US20250206718A1 (en) Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereof
CN103717069B (zh) 有机化合物
CN119585256A (zh) 趋化因子受体调节剂及其用途
WO2018187509A1 (fr) Composés hétérocycliques utilisés en tant que modulateurs du récepteur de chimiokine
AU2016213030B2 (en) Preventive and/or therapeutic agent of immune disease
JP2022053557A (ja) ピリドン誘導体
EA049302B1 (ru) Триазолопиримидины как ингибиторы a2a/a2b
WO2025101571A1 (fr) Agents de dégradation de bcl-x l hétérobifonctionnels de tétrahydroisoquinoléine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18720840

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18720840

Country of ref document: EP

Kind code of ref document: A1